Go to
JCI Insight
Citations to this article
Savannah F. Pedersen, Ya-Chi Ho
Published March 27, 2020
Citation Information: J Clin Invest. 2020;130(5):2202-2205. https://doi.org/10.1172/JCI137647.
Citation Information: J Clin Invest. 2020;130(5):2202-2205. https://doi.org/10.1172/JCI137647.
Abstract
The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunological characteristics between moderate and severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10, and TNF-α), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFN-γ expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design.
Authors
Savannah F. Pedersen, Ya-Chi Ho
Total citations by year
Citation information
Citations to this article (742)
| Title and authors | Publication | Year |
|---|---|---|
|
Deciphering the Complexities of Adult Human Steady State and Stress-Induced Hematopoiesis: Progress and Challenges
Watt SM, Roubelakis MG |
International Journal of Molecular Sciences | 2025 |
|
A20 as a Potential Therapeutic Target for COVID‐19
Wu Y, He L, Li R, Li J, Zhao Q, Shao B |
Immunity, Inflammation and Disease | 2025 |
|
Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
Moharram FA, Ibrahim RR, Mahgoub S, Abdel-Aziz MS, Said AM, Huang HC, Chen LY, Lai KH, Hashad N, Mady MS |
PLOS ONE | 2025 |
|
Risk of neonatal SARS-CoV-2 infection: a retrospective cohort study based on infected mothers with gestational diabetes mellitus
Ni J, Zheng Y, Tian J, Zhang L, Duan S |
Frontiers in Endocrinology | 2025 |
|
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19
Zayou L, Prakash S, Vahed H, Dhanushkodi NR, Quadiri A, Belmouden A, Lemkhente Z, Chentoufi A, Gil D, Ulmer JB, BenMohamed L |
Frontiers in Immunology | 2025 |
|
Metabolomic characteristics and related pathways in patients with different severity of COVID-19: a systematic review and meta-analysis
Bi C, He J, Yuan Y, Che S, Cui T, Ning L, Li Y, Dou Z, Han L |
Journal of Global Health | 2025 |
|
Decoding Inflammation: The Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Critical Outcomes in COVID-19 Patients
Adamescu AI, Tilișcan C, Stratan LM, Mihai N, Ganea OA, Ciobanu S, Marinescu AG, Aramă V, Aramă ȘS |
Medicina | 2025 |
|
Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study.
Mariniello DF, Pagliaro R, D'Agnano V, Schiattarella A, Perrotta F, Bianco A |
Pharmacy (Basel, Switzerland) | 2025 |
|
Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
Nembot Fogang BA, Debrah LB, Owusu M, Agyei G, Meyer J, Gmanyami JM, Ritter M, Arndts K, Adu Mensah D, Adjobimey T, Hörauf A, Debrah AY |
Vaccines | 2025 |
|
What is the actual relationship between neutrophil extracellular traps and COVID-19 severity? A longitudinal study.
de Diego C, Lasierra AB, López-Vergara L, Torralba L, Ruiz de Gopegui P, Lahoz R, Abadía C, Godino J, Cebollada A, Jimeno B, Bello C, Tejada A, Bello S |
Respiratory Research | 2024 |
|
Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications
Zahedipour F, Zahedipour F, Zamani P, Jaafari MR, Sahebkar A |
Virus Research | 2024 |
|
A monoclonal antibody masking the receptor binding domain of spike protein confers broad protection against SARS-CoV-2 Omicron sublineages
Yi-Hsuan Chang, Min-Feng Hsu, Wei-Nan Chen, Min-Hao Wu, Wye Kong, Mei-Yeh Lu, Chih-Heng Huang, Fan-Ju Chang, Lan-Yi Chang, Ho-Yang Tsai, Chao-Ping Tung, Jou-Hui Yu, Yali Kuo, Yu-Chi Chou, Li-Yang Bai, Yuan-Chih Chang, An-Yu Chen, Cheng-Cheung Chen, Chun-Che Liao, Chih-Shin Chang, Jian-Jong Liang, Yi-Ling Lin, Takashi Angata, Shang-Te Hsu, Kuo-I Lin |
JCI Insight | 2024 |
|
A Narrative Review: The Role of NETs in Acute Respiratory Distress Syndrome/Acute Lung Injury
Zhou X, Jin J, Lv T, Song Y |
International journal of molecular sciences | 2024 |
|
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients.
Kaneko T, Ezra S, Abdo R, Voss C, Zhong S, Liu X, Hovey O, Slessarev M, Van Nynatten LR, Ye M, Fraser D, Li SS |
Clinical Proteomics | 2024 |
|
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model.
Prakash S, Dhanushkodi NR, Singer M, Quadiri A, Zayou L, Vahed H, Coulon PG, Ibraim IC, Tafoya C, Hitchcock L, Landucci G, Forthal DN, El Babsiri A, Tifrea DF, Figueroa CJ, Nesburn AB, Kuppermann BD, Gil D, Jones TM, Ulmer JB, BenMohamed L |
bioRxiv : the preprint server for biology | 2024 |
|
Made to order: emergency myelopoiesis and demand-adapted innate immune cell production.
Swann JW, Olson OC, Passegué E |
Nature reviews. Immunology | 2024 |
|
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?
Adamidis PS, Pantazi D, Moschonas IC, Liberopoulos E, Tselepis AD |
Journal of Cardiovascular Development and Disease | 2024 |
|
Changes in the innate immune response to SARS-CoV-2 with advancing age in humans.
Agrawal S, Tran MT, Jennings TSK, Soliman MMH, Heo S, Sasson B, Rahmatpanah F, Agrawal A |
Immunity & ageing : I & A | 2024 |
|
Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review.
Beurton A, Kooistra EJ, De Jong A, Schiffl H, Jourdain M, Garcia B, Vimpère D, Jaber S, Pickkers P, Papazian L |
Current Obesity Reports | 2024 |
|
Association of Coagulopathy and Inflammatory Biomarkers with Severity in SARS-CoV-2-Infected Individuals of the Al-Qunfudhah Region of Saudi Arabia.
Izhari MA, Hadadi MAA, Alharbi RA, Gosady ARA, Sindi AAA, Dardari DMM, Alotaibi FE, Klufah F, Albanghali MA, Alharbi TH |
2024 | |
|
High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4(+) and CD8(+) memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients.
Coulon PG, Prakash S, Dhanushkodi NR, Srivastava R, Zayou L, Tifrea DF, Edwards RA, Figueroa CJ, Schubl SD, Hsieh L, Nesburn AB, Kuppermann BD, Bahraoui E, Vahed H, Gil D, Jones TM, Ulmer JB, BenMohamed L |
Frontiers in immunology | 2024 |
|
Spectrum of COVID-19 induced liver injury: A review report
Singh L, Kumar A, Rai M, Basnet B, Rai N, Khanal P, Lai KS, Cheng WH, Asaad AM, Ansari S |
World journal of hepatology | 2024 |
|
Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review
Riou M, Coste F, Meyer A, Enache I, Talha S, Charloux A, Reboul C, Geny B |
International journal of molecular sciences | 2024 |
|
SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients.
Izhari MA |
Infection and drug resistance | 2024 |
|
The Dysregulation of the Monocyte–Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia
Galati D, Mallardo D, Nicastro C, Zanotta S, Capitelli L, Lombardi C, Baino B, Cavalcanti E, Sale S, Labonia F, Boenzi R, Atripaldi L, Ascierto PA, Bocchino M |
Journal of Clinical Medicine | 2024 |
|
A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications
Prasanth MI, Wannigama DL, Reiersen AM, Thitilertdecha P, Prasansuklab A, Tencomnao T, Brimson S, Brimson JM |
Scientific Reports | 2024 |
|
NSAIDs for early management of acute respiratory infections
Bassetti M, Andreoni M, Santus P, Scaglione F |
Current Opinion in Infectious Diseases | 2024 |
|
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
Kozłowski P, Leszczyńska A, Ciepiela O |
2024 | |
|
Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
Rajaiah R, Pandey K, Acharya A, Ambikan A, Kumar N, Guda R, Avedissian SN, Montaner LJ, Cohen SM, Neogi U, Byrareddy SN |
iScience | 2024 |
|
Modelling the long-term health impact of COVID-19 using Graphical Chain Models brief heading: long COVID prediction by graphical chain models
Gourgoura K, Rivadeneyra P, Stanghellini E, Caroni C, Bartolucci F, Curcio R, Bartoli S, Ferranti R, Folletti I, Cavallo M, Sanesi L, Dominioni I, Santoni E, Morgana G, Pasticci MB, Pucci G, Vaudo G |
BMC Infectious Diseases | 2024 |
|
Could Ocular Glands Be Infected by SARS-CoV-2?
Bu J, Zhang M, Zhang R, Sun L, Chen Z, Wu Y |
Diseases | 2024 |
|
The usage of immunosuppressant agents and secondary infections in patients with COVID-19 in the intensive care unit: a retrospective study.
Sarikaya ZT, Gucyetmez B, Tuzuner F, Dincer O, Sahan C, Dogan L, Yildirim SA, Zengin R, Kocagoz AS, Telci L, Akinci IO |
Scientific reports | 2024 |
|
Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19
Zayou L, Prakash S, Vahed H, Dhanushkodi NR, Quadiri A, Belmouden A, Lemkhente Z, Chentoufi A, Gil D, Ulmer JB, BenMohamed L |
bioRxiv | 2024 |
|
Molecular Characterization and Genomic Surveillance of SARS-CoV-2 Lineages in Central India.
Dwivedi P, Sharma M, Ansari A, Ghosh A, Bishwal SC, Ray SK, Katiyar M, Kombiah S, Kumar A, Sahare L, Ukey M, Barde PV, Das A, Singh P |
Viruses | 2024 |
|
The neutrophil extracellular traps in neurological diseases: an update.
Yu X, Chen Z, Bao W, Jiang Y, Ruan F, Wu D, Le K |
Clinical and experimental immunology | 2024 |
|
Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID‐19
Valderrábano RJ, Wipper B, Pencina KM, Migaud M, Shang YV, Latham NK, Montano M, Cunningham JM, Wilson L, Peng L, Memish\u2010Beleva Y, Bhargava A, Swain PM, Lehman P, Lavu S, Livingston DJ, Bhasin S |
Aging Cell | 2024 |
|
Cytokine Storm among Bangladeshi adults with COVID-19: A prospective cohort study
Sarmin M, Akter F, Islam AN, Mahfuz M, Das S, Sharifuzzaman, Hasan SM, Bhuiyan TR, Rahman M, Gazi A, Matin FB, Tariqujjaman M, Shahrin L, Islam M, Mahmud AM, Banu S, Chisti MJ, Qadri F, Clemens JD, Ahmed T |
Heliyon | 2024 |
|
Biomechanics Model to Characterize Atomic Force Microscopy-Based Virus–Host Cell Adhesion Measurements
Wang J, Ziarnik M, Zhang XF, Jagota A |
The Journal of Physical Chemistry. B | 2024 |
|
The effect of the pandemic on autoantibody rates in the general population
Karabey M, Kaya H, Ceylan A, Kaba K, Özdemir M, Feyzioğlu B |
Archives of Rheumatology | 2024 |
|
Hypoxia modeling techniques: A review
Salyha N, Oliynyk I |
Heliyon | 2023 |
|
COVID-19 in patients with pre-existing chronic liver disease – predictors of outcomes
Walia D, Saraya A, Gunjan D |
World Journal of Virology | 2023 |
|
Anti-inflammatory or anti-SARS-CoV-2 ingredients in Huashi Baidu Decoction and their corresponding targets: target screening and molecular docking study
Wang Z, Gao H |
Arabian Journal of Chemistry | 2023 |
|
Different cytokine and chemokine profiles in hospitalized patients with COVID-19 during the first and second outbreaks from Argentina show no association with clinical comorbidities
Almada L, Angiolini SC, Dho ND, Dutto J, Gazzoni Y, Manzone-Rodríguez C, Marín C, Ponce NE, Arroyo DS, Quiróz JN, Iribarren P, Cerbán FM, Morón G, Amezcua Vesely MC, Cervi L, Chiapello LS, Fozzatti L, Icely PA, Maccioni M, Montes CL, Motrán CC, Rodríguez-Galán MC, Stempin CC, Viano ME, Mena C, Bertone M, Abiega CD, Escudero D, Kahn A, Caeiro JP, Maletto BA, Acosta Rodríguez EV, Gruppi A, Sotomayor CE |
Frontiers in immunology | 2023 |
|
Coronavirus disease 2019 information-seeking behavior globally: a systematic review
Anagaw TF, Guadie HA |
SAGE Open Medicine | 2023 |
|
Relation of COVID-19 with liver diseases and their impact on healthcare systems: The Portuguese case
Fernandes S, Sosa-Napolskij M, Lobo G, Silva I |
World Journal of Gastroenterology | 2023 |
|
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination
Scola L, Ferraro D, Sanfilippo GL, De Grazia S, Lio D, Giammanco GM |
Human vaccines | 2023 |
|
Aptamer-based Emerging Tools for Viral Biomarker Detection: A Focus on SARS-CoV-2.
Kulabhusan PK, Pishva P, Çapkın E, Tambe P, Yüce M |
Current medicinal chemistry | 2023 |
|
Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital
Punzalan FE, Aherrera JA, de Paz-Silava SL, Mondragon AV, Malundo AF, Tan JJ, Tantengco OA, Quebral EP, Uy MN, Lintao RC, Dela Rosa JG, Mercado ME, Avenilla KC, Poblete JB, Albay AB Jr, David-Wang AS, Alejandria MM |
Frontiers in immunology | 2023 |
|
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Purbey PK, Roy K, Gupta S, Paul MK |
Molecular Immunology | 2023 |
|
Characterization of T Helper 1 and 2 Cytokine Profiles in Newborns of Mothers with COVID-19
Moreira AL, da Silva PA, Gomes RS, Santos MD, Ito CR, Barbosa LC, de Souza PP, Peixoto FA, Wastowski IJ, Carneiro LC, Avelino MA |
Biomedicines | 2023 |
|
Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma
Gomez-Lopez N, Romero R, Escobar MF, Carvajal JA, Echavarria MP, Albornoz LL, Nasner D, Miller D, Gallo DM, Galaz J, Arenas-Hernandez M, Bhatti G, Done B, Zambrano MA, Ramos I, Fernandez PA, Posada L, Chaiworapongsa T, Jung E, Garcia-Flores V, Suksai M, Gotsch F, Bosco M, Than NG, Tarca AL |
2023 | |
|
Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation
Wang D, Gomes MT, Mo Y, Prohaska CC, Zhang L, Chelvanambi S, Clauss MA, Zhang D, Machado RF, Gao M, Bai Y |
International journal of molecular sciences | 2023 |
|
Severe COVID-19: Drugs and Clinical Trials
Ceja-Gálvez HR, Renteria-Flores FI, Nicoletti F, Hernández-Bello J, Macedo-Ojeda G, Muñoz-Valle JF |
Journal of Clinical Medicine | 2023 |
|
Liver manifestations in COVID-19 patients: A review article
Helou M, Nasr J, El Osta N, Jabbour E, Husni R |
World journal of clinical cases | 2023 |
|
Cellular and Humoral Immune Responses to Vaccination for COVID-19 Are Negatively Impacted by Senescent T Cells: A Case Report
Rosseto-Welter EA, Rodrigues SS, de Figueiredo AB, França CN, Oliveira DB, Bachi AL, do Amaral JB, Siqueira RA, Bento LC, da Silva AP, Bacal NS, dos Santos Ferreira CE, Mangueira CL, Pinho JR |
Human vaccines | 2023 |
|
Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
Escudero-Pérez B, Lawrence P, Castillo-Olivares J |
Frontiers in immunology | 2023 |
|
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles.
Navarini L, Vomero M, Currado D, Berardicurti O, Biaggi A, Marino A, Bearzi P, Corberi E, Rigon A, Arcarese L, Leuti A, Fava M, Fogolari M, Mattei A, Ruscitti P, Di Cola I, Sambuco F, Travaglino F, Angeletti S, Ursini F, Mariani E, Cipriani P, Agrò FE, Iagnocco A, Antonelli Incalzi R, Maccarrone M, Giacomelli R |
Frontiers in immunology | 2023 |
|
Obesity and Viral Infections.
Jaisinghani P, Kumar R |
Gastroenterology Clinics of North America | 2023 |
|
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
Kumar S, Basu M, Ghosh P, Pal U, Ghosh MK |
Genes & Diseases | 2023 |
|
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Shen J, Fan J, Zhao Y, Jiang D, Niu Z, Zhang Z, Cao G |
Frontiers in immunology | 2023 |
|
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review
Ghosn L, Assi R, Evrenoglou T, Buckley BS, Henschke N, Probyn K, Riveros C, Davidson M, Graña C, Bonnet H, Jarde A, Ávila C, Nejstgaard CH, Menon S, Ferrand G, Kapp P, Breuer C, Schmucker C, Sguassero Y, Nguyen TV, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P, Chaimani A, Boutron I |
The Cochrane Database of Systematic Reviews | 2023 |
|
Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study
Ergun T, Hosgoren Tekin S, Apti Sengun O, Akin Cakici O, Seckin D, Adiay C, Enul H, Yilmaz S, Ay P, Haklar G, Sili U |
Vaccine | 2023 |
|
Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
Shah D, Soper B, Shopland L |
Frontiers in immunology | 2023 |
|
Ensemble Deep Learning Derived from Transfer Learning for Classification of COVID-19 Patients on Hybrid Deep-Learning-Based Lung Segmentation: A Data Augmentation and Balancing Framework
Dubey AK, Chabert GL, Carriero A, Pasche A, Danna PS, Agarwal S, Mohanty L, Nillmani, Sharma N, Yadav S, Jain A, Kumar A, Kalra MK, Sobel DW, Laird JR, Singh IM, Singh N, Tsoulfas G, Fouda MM, Alizad A, Kitas GD, Khanna NN, Viskovic K, Kukuljan M, Al-Maini M, El-Baz A, Saba L, Suri JS |
Diagnostics | 2023 |
|
Soluble CD4 effectively prevents excessive TLR activation of resident macrophages in the onset of sepsis.
Zhang SY, Xu QP, Shi LN, Li SW, Wang WH, Wang QQ, Lu LX, Xiao H, Wang JH, Li FY, Liang YM, Gong ST, Peng HR, Zhang Z, Tang H |
Signal Transduction and Targeted Therapy | 2023 |
|
Highly-specific aptamer targeting SARS-CoV-2 S1 protein screened on an automatic integrated microfluidic system for COVID-19 diagnosis
Wu HB, Wang CH, Chung YD, Shan YS, Lin YJ, Tsai HP, Lee GB |
Analytica Chimica Acta | 2023 |
|
Documenting the immune response in patients with COVID-19-induced acute respiratory distress syndrome
Lu J, Zeng X, Lu W, Feng J, Yang Y, Wei Y, Chen Y, Zhang J, Pinhu L |
Frontiers in Cell and Developmental Biology | 2023 |
|
Exploring the Potential of GANs in Biological Sequence Analysis
Murad T, Ali S, Patterson M |
Biology | 2023 |
|
Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence
Bai X, Schountz T, Buckle AM, Talbert JL, Sandhaus RA, Chan ED |
Biochemical Society Transactions | 2023 |
|
Mitigating neutrophil trafficking and cardiotoxicity with DS-IkL in a microphysiological system of a cytokine storm
Shirure VS, Yechikov S, Shergill BS, Dehghani T, Block AV, Sodhi H, Panitch A, George SC |
Lab on a Chip | 2023 |
|
Inflammation and Immune Reactions in the Fetus as a Response to COVID-19 in the Mother.
Gashimova NR, Pankratyeva LL, Bitsadze VO, Khizroeva JK, Tretyakova MV, Grigoreva KN, Tsibizova VI, Gris JC, Degtyareva ND, Yakubova FE, Makatsariya AD |
Journal of Clinical Medicine | 2023 |
|
T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures
Xu J, Li XX, Yuan N, Li C, Yang JG, Cheng LM, Lu ZX, Hou HY, Zhang B, Hu H, Qian Y, Liu XX, Li GC, Wang YD, Chu M, Dong CR, Liu F, Ge QG, Yang YJ |
Frontiers in immunology | 2023 |
|
Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections.
Ruiz-Cáceres I, Hermida Romero T, Guerra Merino I, Portu Zapirain J, Pérez-Mies B, Sánchez-Conde M, Riaño MA, Rubio R, Fortés Alen J, Vidal González Á, Salas Antón C, Múñez E, Sánchez Sánchez R, Corona-Mata D, Aldecoa Ansorregui I, Miró JM, Beloqui Pérez de Obanos R, Ibero C, Gómez-Román J, Fariñas MC, Tabuyo Bello T, de Alava E, Cisneros JM, Matías-Guiu X, Rivero A |
Frontiers in Medicine | 2023 |
|
Polypharmacology guided drug repositioning approach for SARS-CoV2
Jamir E, Sarma H, Priyadarsinee L, Kiewhuo K, Nagamani S, Sastry GN |
PloS one | 2023 |
|
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
Luxenburger H, Thimme R |
Gut | 2023 |
|
Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
Yu F, He H, Huang T, Zhou Y |
Open Life Sciences | 2023 |
|
Acute necrotizing encephalopathy in children with COVID-19: a retrospective study of 12 cases
Lin X, Wang Y, Li X, Abdalla M, Zhang F, Dong C, Lu W, Liu X, Zhang J, Ma K, Ma X, Jiang Q |
Frontiers in neurology | 2023 |
|
Long-term multiple metabolic abnormalities among healthy and high-risk people following nonsevere COVID-19.
Washirasaksiri C, Sayabovorn N, Ariyakunaphan P, Kositamongkol C, Chaisathaphol T, Sitasuwan T, Tinmanee R, Auesomwang C, Nimitpunya P, Woradetsittichai D, Chayakulkeeree M, Phoompoung P, Mayurasakorn K, Sookrung N, Tungtrongchitr A, Wanitphakdeedecha R, Muangman S, Senawong S, Tangjittipokin W, Sanpawitayakul G, Nopmaneejumruslers C, Vamvanij V, Phisalprapa P, Srivanichakorn W |
Scientific Reports | 2023 |
|
Asthma and COVID-19: a controversial relationship.
Dounce-Cuevas CA, Flores-Flores A, Bazán MS, Portales-Rivera V, Morelos-Ulíbarri AA, Bazán-Perkins B |
Virology Journal | 2023 |
|
Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury
Sun G, Wang B, Zhu H, Ye J, Liu X |
Frontiers in Medicine | 2023 |
|
Impact of clinico-biochemical and inflammatory biomarkers on the immunogenicity and efficacy of SARS-CoV-2 adenoviral vaccine: a longitudinal study
Majid S, Khan MS, Nisar N, Bhat JA, Haq I, Khan SM |
Journal of Circulating Biomarkers | 2023 |
|
TNFα rs1800629 Polymorphism and Response to Anti-TNFα Treatment in Behçet Syndrome: Data from an Italian Cohort Study
Padula MC, Padula AA, D\u2019Angelo S, Lascaro N, Radice RP, Martelli G, Leccese P |
Journal of Personalized Medicine | 2023 |
|
An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Zhang HQ, Cao BZ, Cao QT, Hun M, Cao L, Zhao MY |
Human Vaccines & Immunotherapeutics | 2023 |
|
Immunodominant conserved moieties on spike protein of SARS-CoV-2 renders virulence factor for the design of epitope-based peptide vaccines.
Mohapatra S, Kumar S, Kumar S, Singh AK, Nayak B |
VirusDisease | 2023 |
|
Intracranial hemorrhages in patients with COVID-19: a systematic review of the literature, regarding six cases in an Amazonian population.
Lima WS, Soares MHP, Paschoal EHA, Paschoal JKSF, Paschoal FM Jr, Bor-Seng-Shu E |
Arquivos de Neuro-Psiquiatria | 2023 |
|
Evaluation of IL-6, IL-25 & IL-35 in the COVID 19 Patients and their Correlation to Demography Data in the Symptomatic Patients.
Mohammed H Al-Mquter LF, Abdul Azeez Atiayh S |
Archives of Razi Institute | 2023 |
|
Symmetrical peripheral gangrene: potential mechanisms and therapeutic approaches in severe COVID-19
Wang M, Sun T, Dong L, Huang S, Liu J |
Frontiers in Cardiovascular Medicine | 2023 |
|
Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity
Wolszczak-Biedrzycka B, Dorf J, Wojewódzka-Żelezniakowicz M, Żendzian-Piotrowska M, Dymicka-Piekarska VJ, Matowicka-Karna J, Maciejczyk M |
Journal of inflammation research | 2023 |
|
Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations
Alarabei AA, Abd Aziz NA, AB Razak NI, Abas R, Bahari H, Abdullah MA, Hussain MK, Abdul Majid AM, Basir R |
Advanced pharmaceutical bulletin | 2023 |
|
Zinc Deficiency And sTNF-RII Are Associated With Worse COVID-19 Outcomes
Mouchati C, Durieux JC, Zisis SN, Tribout H, Scott S, Smith B, Labbato D, McComsey GA |
The Journal of Nutrition | 2023 |
|
Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19
Xinge Wang, Mark A Sanborn, Yang Dai, Jalees Rehman |
JCI Insight | 2022 |
|
Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19
Kuang-Den Chen, Ying-Hsien Huang, Wei-Sheng Wu, Chiao-Lun Chu, Ho-Chang Kuo |
Frontiers in immunology | 2022 |
|
A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?
A Toro, M Ruiz, S Lage-Vickers, P Sanchis, A Sabater, G Pascual, R Seniuk, F Cascardo, S Ledesma-Bazan, F Vilicich, E Vazquez, G Gueron |
Antioxidants | 2022 |
|
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective
D Menter, V Afshar-Kharghan, J Shen, S Martch, A Maitra, S Kopetz, K Honn, A Sood |
Cancer and Metastasis Reviews | 2022 |
|
Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance
R Lucas, Y Hadizamani, P Enkhbaatar, G Csanyi, R Caldwell, H Hundsberger, S Sridhar, A Lever, M Hudel, D Ash, M Ushio-Fukai, T Fukai, T Chakraborty, A Verin, D Eaton, M Romero, J Hamacher |
Frontiers in physiology | 2022 |
|
COVID-19 and cancer: start the resolution!
C Barksdale, F Kipper, S Tripathy, S Subbian, C Serhan, D Panigrahy |
Cancer and Metastasis Reviews | 2022 |
|
Pathophysiological and molecular considerations of viral and bacterial infections during maternal-fetal and –neonatal interactions of SARS-CoV-2, Zika, and Mycoplasma infectious diseases
G Ferreira, F Blasina, MR Rey, G Anesetti, R Sapiro, L Chavarría, R Cardozo, G Rey, L Sobrevia, GL Nicolson |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2022 |
|
Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction
R Ahmad, M Haque |
Human vaccines | 2022 |
|
Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults
M Girona-Alarcon, G Argüello, A Esteve-Sole, S Bobillo-Perez, XP Burgos-Artizzu, E Bonet-Carne, A Mensa-Vilaró, A Codina, M Hernández-Garcia, C Jou, L Alsina, I Jordan |
iScience | 2022 |
|
On the Origin of Neutrophil Extracellular Traps in COVID-19
M Pastorek, M Dúbrava, P Celec |
Frontiers in immunology | 2022 |
|
Therapeutic role of immunomodulators during the COVID-19 pandemic– a narrative review
H Al-Hajeri, F Baroun, F Abutiban, M Al-Mutairi, Y Ali, A Alawadhi, A Albasri, A Aldei, A AlEnizi, N Alhadhood, A Al-Herz, A Alkadi, W Alkanderi, A Almathkoori, N Almutairi, S Alsayegh, A Alturki, H Bahbahani, A Dehrab, A Ghanem, E Hasan, S Hayat, K Saleh, H Tarakmeh |
Postgraduate Medicine | 2022 |
|
Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19
A Sen, A Nigam, M Vachher |
International Journal of Peptide Research and Therapeutics | 2022 |
|
The mechanistic basis linking cytokine storm to thrombosis in COVID-19
Wolf A, Khimani F, Yoon B, Gerhart C, Endsley D, Ray AK, Yango AF, Flynn SD, Lip GY, Gonzalez SA, Sathyamoorthy M |
2022 | |
|
Immune system changes in those with hypertension when infected with SARS-CoV-2
Su S, Chen R, Zhang S, Shu H, Luo J |
Cellular Immunology | 2022 |
|
Tocilizumab and COVID-19: Timing of Administration and Efficacy.
Abidi E, El Nekidy WS, Alefishat E, Rahman N, Petroianu GA, El-Lababidi R, Mallat J |
Frontiers in pharmacology | 2022 |
|
Experimental Models to Study the Pathogenesis of Malaria-Associated Acute Respiratory Distress Syndrome
Nguee SY, Júnior JW, Epiphanio S, Rénia L, Claser C |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
Ma Y, Qiu F, Deng C, Li J, Huang Y, Wu Z, Zhou Y, Zhang Y, Xiong Y, Yao Y, Zhong Y, Qu J, Su J |
Genome Medicine | 2022 |
|
Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women
Gomez-Lopez N, Romero R, Tao L, Gershater M, Leng Y, Zou C, Farias-Jofre M, Galaz J, Miller D, Tarca AL, Arenas-Hernandez M, Bhatti G, Garcia-Flores V, Liu Z, Para R, Kanninen T, Hadaya O, Paredes C, Xu Y |
Journal of immunology (Baltimore, Md. : 1950) | 2022 |
|
Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro.
Raghavan PR |
BioMed Research International | 2022 |
|
Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection.
Shchetinin E, Baturin V, Arushanyan E, Bolatchiev A, Bobryshev D |
2022 | |
|
The prognostic role of micronutrient status and supplements in COVID-19 outcomes: A systematic review.
Pechlivanidou E, Vlachakis D, Tsarouhas K, Panidis D, Tsitsimpikou C, Darviri C, Kouretas D, Bacopoulou F |
Food and Chemical Toxicology | 2022 |
|
Remote management of osteoporosis in the first wave of the COVID-19 pandemic.
Salvio G, Gianfelice C, Firmani F, Lunetti S, Ferroni R, Balercia G, Giacchetti G |
Archives of Osteoporosis | 2022 |
|
In silico anti-SARS-CoV-2 activities of five-membered heterocycle-substituted benzimidazoles.
Mudi PK, Mahato RK, Verma H, Panda SJ, Purohit CS, Silakari O, Biswas B |
Journal of Molecular Structure | 2022 |
|
Performance of early warning signals for disease re-emergence: A case study on COVID-19 data.
Proverbio D, Kemp F, Magni S, Gonçalves J |
PLoS computational biology | 2022 |
|
Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
Yang X, Rutkovsky AC, Zhou J, Zhong Y, Reese J, Schnell T, Albrecht H, Owens WB, Nagarkatti PS, Nagarkatti M |
Journal of immunology (Baltimore, Md. : 1950) | 2022 |
|
Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19.
Kocherlakota C, Nagaraju B, Arjun N, Srinath A, Kothapalli KSD, Brenna JT |
Prostaglandins, leukotrienes, and essential fatty acids | 2022 |
|
Deciphering the immunoboosting potential of macro and micronutrients in COVID support therapy.
Batiha GE, Al-Gareeb AI, Qusti S, Alshammari EM, Kaushik D, Verma R, Al-Kuraishy HM |
Environmental Science and Pollution Research | 2022 |
|
In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition.
Ničkčović VP, Nikolić GR, Nedeljković BM, Mitić N, Danić SF, Mitić J, Marčetić Z, Sokolović D, Veselinović AM |
2022 | |
|
Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19.
Brancaccio M, Mennitti C, Calvanese M, Gentile A, Musto R, Gaudiello G, Scamardella G, Terracciano D, Frisso G, Pero R, Sarno L, Guida M, Scudiero O |
International journal of molecular sciences | 2022 |
|
In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release.
Dolci M, Signorini L, D'Alessandro S, Perego F, Parapini S, Sommariva M, Taramelli D, Ferrante P, Basilico N, Delbue S |
International journal of molecular sciences | 2022 |
|
COVID-19: The question of genetic diversity and therapeutic intervention approaches.
Figueiredo DLA, Ximenez JPB, Seiva FRF, Panis C, Bezerra RDS, Ferrasa A, Cecchini AL, Medeiros AI, Almeida AMF, Ramão A, Boldt ABW, Moya CF, Chin CM, Paula D, Rech D, Gradia DF, Malheiros D, Venturini D, Tavares ER, Carraro E, Ribeiro EMSF, Pereira EM, Tuon FF, Follador FAC, Fernandes GSA, Volpato H, Cólus IMS, Oliveira JC, Rodrigues JHDS, Santos JLD, Visentainer JEL, Brandi JC, Serpeloni JM, Bonini JS, Oliveira KB, Fiorentin K, Lucio LC, Faccin-Galhardi LC, Ferreto LED, Lioni LMY, Consolaro MEL, Vicari MR, Arbex MA, Pileggi M, Watanabe MAE, Costa MAR, Giannini MJSM, Amarante MK, Khalil NM, Lima Neto QA, Herai RH, Guembarovski RL, Shinsato RN, Mainardes RM, Giuliatti S, Yamada-Ogatta SF, Gerber VKQ, Pavanelli WR, Silva WCD, Petzl-Erler ML, Valente V, Soares CP, Cavalli LR, Silva WA Jr |
Genetics and molecular biology | 2022 |
|
COVID-19 and corticosteroids: a narrative review.
El-Saber Batiha G, Al-Gareeb AI, Saad HM, Al-Kuraishy HM |
InflammoPharmacology | 2022 |
|
Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection.
Pence S, Caykara B, Pence HH, Tekin S, Keskin BC, Uncu AT, Uncu AO, Ozturk E |
Northern Clinics of Istanbul | 2022 |
|
The effect of steroids used in the treatment of coronavirus disease 2019 on infections in intensive care.
Sari A, Aslan M, Ekinci O |
Northern Clinics of Istanbul | 2022 |
|
Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort.
Simon D, Tascilar K, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, Orlemann T, Kliem T, Mößner J, Liphardt AM, Schönau V, Bohr D, Schuster L, Hartmann F, Leppkes M, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G |
Arthritis & Rheumatism | 2022 |
|
Seroprevalence of COVID-19 IgG Antibody in Resident and Fellow Physicians in Milwaukee, Wisconsin: Analysis of a Cross-Sectional Survey.
Baumgardner DJ, Schwank A, Kram JJF, Lehmann W, Bidwell JL, La Fratta T, Copeland K |
Journal of patient-centered research and reviews | 2022 |
|
Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown.
Desquilles L, Cano L, Ghukasyan G, Mouchet N, Landreau C, Corlu A, Clément B, Turlin B, Désert R, Musso O |
Scientific Reports | 2022 |
|
Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences.
Shiraki K, Sato N, Sakai K, Matsumoto S, Kaszynski RH, Takemoto M |
Pharmacology & Therapeutics | 2022 |
|
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
Mera-Cordero F, Bonet-Monne S, Almeda-Ortega J, García-Sangenís A, Cunillera-Puèrtolas O, Contreras-Martos S, Alvarez-Muñoz G, Monfà R, Balanzo-Joué M, Morros R, Salvador-Gonzalez B |
Trials | 2022 |
|
Two-dimensional material-based virus detection.
Wang W, Zhai W, Chen Y, He Q, Zhang H |
Science China Chemistry | 2022 |
|
Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia.
Ruiz-Rodríguez JC, Chiscano-Camón L, Ruiz-Sanmartin A, Palmada C, Paola Plata-Menchaca E, Franco-Jarava C, Pérez-Carrasco M, Hernández-González M, Ferrer R |
Frontiers in Medicine | 2022 |
|
Automatic Deep-Learning Segmentation of Epicardial Adipose Tissue from Low-Dose Chest CT and Prognosis Impact on COVID-19.
Bartoli A, Fournel J, Ait-Yahia L, Cadour F, Tradi F, Ghattas B, Cortaredona S, Million M, Lasbleiz A, Dutour A, Gaborit B, Jacquier A |
Cells | 2022 |
|
Virus-Induced Maternal Immune Activation as an Environmental Factor in the Etiology of Autism and Schizophrenia.
Massrali A, Adhya D, Srivastava DP, Baron-Cohen S, Kotter MR |
Frontiers in neuroscience | 2022 |
|
Applying polypharmacology approach for drug repurposing for SARS-CoV2.
Jamir E, Sarma H, Priyadarsinee L, Nagamani S, Kiewhuo K, Gaur AS, Rawal RK, Murugan NA, Subramanian V, Sastry GN |
2022 | |
|
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19.
Lu T, Ma R, Dong W, Teng KY, Kollath DS, Li Z, Yi J, Bustillos C, Ma S, Tian L, Mansour AG, Li Z, Settles EW, Zhang J, Keim PS, Barker BM, Caligiuri MA, Yu J |
Nature Communications | 2022 |
|
COVID-19 infections in infants.
Sobolewska-Pilarczyk M, Pokorska-Śpiewak M, Stachowiak A, Marczyńska M, Talarek E, Ołdakowska A, Kucharek I, Sybilski A, Mania A, Figlerowicz M, Mazur-Melewska K, Potocka P, Sulik A, Hasiec B, Stani M, Frańczak-Chmura P, Szczepańska B, Pałyga-Bysiecka I, Ciechanowski P, Łasecka-Zadrożna J, Zaleska I, Szenborn L, Dryja U, Kuchar E, Niedźwiecka S, Kalicki B, Flisiak R, Pawłowska M |
Scientific Reports | 2022 |
|
Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation
Gál P, Brábek J, Holub M, Jakubek M, Šedo A, Lacina L, Strnadová K, Dubový P, Hornychová H, Ryška A, Smetana K Jr |
Histochemistry and Cell Biology | 2022 |
|
Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.
Grandone E, Vimercati A, Sorrentino F, Colaizzo D, Ostuni A, Ceci O, Capozza M, Tiscia G, De Laurenzo A, Mastroianno M, Cappucci F, Fischetti L, Margaglione M, Cicinelli E, Nappi L |
BMC pregnancy and childbirth | 2022 |
|
Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage.
Laurence J, Nuovo G, Racine-Brzostek SE, Seshadri M, Elhadad S, Crowson AN, Mulvey JJ, Harp J, Ahamed J, Magro C |
The American Journal of Pathology | 2022 |
|
Probing the formation, structure and free energy relationships of M protein dimers of SARS-CoV-2
Cao Y, Yang R, Wang W, Jiang S, Yang C, Liu N, Dai H, Lee I, Meng X, Yuan Z |
Computational and Structural Biotechnology Journal | 2022 |
|
Cancer Occurrence as the Upcoming Complications of COVID-19
Rahimmanesh I, Shariati L, Dana N, Esmaeili Y, Vaseghi G, Haghjooy Javanmard S |
Frontiers in Molecular Biosciences | 2022 |
|
Tip of the iceberg: erectile dysfunction and COVID-19
Kaynar M, Gomes AL, Sokolakis I, Gül M |
International Journal of Impotence Research | 2022 |
|
Blood purification in sepsis and COVID-19: what´s new in cytokine and endotoxin hemoadsorption
Ruiz-Rodríguez JC, Plata-Menchaca EP, Chiscano-Camón L, Ruiz-Sanmartin A, Ferrer R |
2022 | |
|
Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm
Li H, You J, Yang X, Wei Y, Zheng L, Zhao Y, Huang Y, Jin Z, Yi C |
Phytomedicine | 2022 |
|
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Ripamonti C, Spadotto V, Pozzi P, Stevenazzi A, Vergani B, Marchini M, Sandrone G, Bonetti E, Mazzarella L, Minucci S, Steinkühler C, Fossati G |
Frontiers in immunology | 2022 |
|
The association between different predictive biomarkers and mortality of COVID-19
Ansari N, Jahangiri M, Shirbandi K, Ebrahimi M, Rahim F |
2022 | |
|
Reactive arthritis occurring after COVID-19 infection: a narrative review
Slouma M, Abbes M, Mehmli T, Dhahri R, Metoui L, Gharsallah I, Louzir B |
Infection | 2022 |
|
Deleterious effects of nervous system in the offspring following maternal SARS-CoV-2 infection during the COVID-19 pandemic
Wang R, Wu Z, Huang C, Hashimoto K, Yang L, Yang C |
Translational Psychiatry | 2022 |
|
An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model
Hedges JF, Snyder DT, Robison A, Grifka-Walk HM, Blackwell K, Shepardson K, Kominsky D, Rynda-Apple A, Walcheck B, Jutila MA |
Frontiers in immunology | 2022 |
|
Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice
Kim EH, Lee BW, Ryu B, Cho HM, Kim SM, Jang SG, Casel MA, Rollon R, Yoo JS, Poo H, Oh WK, Choi YK |
Antiviral Research | 2022 |
|
Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19
Xia W, Tan Y, Hu S, Li C, Jiang T |
Clinical and Applied Thrombosis/Hemostasis | 2022 |
|
Application of a data-driven XGBoost model for the prediction of COVID-19 in the USA: a time-series study
Fang ZG, Yang SQ, Lv CX, An SY, Wu W |
BMJ Open | 2022 |
|
Yoga, immunity and COVID-19: A scoping review
Shah K, Adhikari C, Saha S, Saxena D |
Journal of Family Medicine and Primary Care | 2022 |
|
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
Trujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Fernández JM, Pérez-Gómez A, Gasca-Capote C, Vitallé J, Peraire J, Palacios-Baena ZR, Cabrera JJ, Ruiz-Mateos E, Poveda E, López-Cortés LE, Rull A, Gutierrez-Valencia A, López-Cortés LF |
PloS one | 2022 |
|
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Qu W, Wang Z, Engelberg-Cook E, Yan D, Siddik AB, Bu G, Allickson JG, Kubrova E, Caplan AI, Hare JM, Ricordi C, Pepine CJ, Kurtzberg J, Pascual JM, Mallea JM, Rodriguez RL, Nayfeh T, Saadi S, Durvasula RV, Richards EM, March K, Sanfilippo FP |
Stem Cells Translational Medicine | 2022 |
|
Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress
Karu N, Kindt A, van Gammeren AJ, Ermens AA, Harms AC, Portengen L, Vermeulen RC, Dik WA, Langerak AW, van der Velden VH, Hankemeier T |
Metabolites | 2022 |
|
SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns
Vazquez-Alejo E, Tarancon-Diez L, Carrasco I, Vigil-Vázquez S, Muñoz-Chapuli M, Rincón-López E, Saavedra-Lozano J, Santos-Sebastián M, Aguilera-Alonso D, Hernanz-Lobo A, Santiago-García B, de León-Luis JA, Muñoz P, Sánchez-Luna M, Navarro ML, Muñoz-Fernández MÁ |
Frontiers in immunology | 2022 |
|
Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics
Sapra L, Saini C, Garg B, Gupta R, Verma B, Mishra PK, Srivastava RK |
Inflammation Research | 2022 |
|
Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases
Shao L, Pelayo A, Shi R, Ma J, Liu H, Cai Y, Prochazkova M, Somerville RP, Panch SR, Shah NN, Stroncek DF, Jin P |
Journal of Translational Medicine | 2022 |
|
Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
Cavuşoğlu Türker B, Türker F, Ahbab S, Hoca E, Urvasızoğlu AO, Cetin SI, Ataoğlu HE |
International journal of general medicine | 2022 |
|
Exploring the Potential of Chemical Inhibitors for Targeting Post-translational Glycosylation of Coronavirus (SARS-CoV-2)
Tripathi N, Goel B, Bhardwaj N, Vishwakarma RA, Jain SK |
ACS Omega | 2022 |
|
Effects of Plant Metabolites on the Growth of COVID-19 (Coronavirus Disease-19) Including Omicron Strain
Bagde H, Dhopte A |
Cureus | 2022 |
|
Exploring extracellular vesicles as mediators of clinical disease and vehicles for viral therapeutics: Insights from the COVID-19 pandemic
Craddock VD, Cook CM, Dhillon NK |
Extracellular vesicles and circulating nucleic acids | 2022 |
|
NK cell dysfunction is linked with disease severity in SARS‐CoV‐2 patients
Dizaji Asl K, Mazloumi Z, Majidi G, Kalarestaghi H, Sabetkam S, Rafat A |
Cell Biochemistry and Function | 2022 |
|
Deep venous thrombosis and acute pericarditis associated with severe acute respiratory syndrome coronavirus 2 infection in a Congolese infant with sickle cell disease: a case report
Lubala TK, Kayembe-Kitenge T, Makinko P, Kalenga L, Kachil H, Kayembe A, Mutombo A, Shongo M |
Journal of medical case reports | 2022 |
|
Novel Hit of DPP-4Is as Promising Antihyperglycemic Agents with Dual Antioxidant /Anti-Inflammatory Effects for Type 2 Diabetic Patients withCOVID-19
Mahgoub S, Fatahala SS, Sayed AI, Atya HB, El-Shehry MF, Afifi H, Awad SM, Abd El-Hameed RH, Taha H |
Bioorganic chemistry | 2022 |
|
Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial
Shamohammadi I, Kazemeyni S, Sadighi M, Hasanzadeh T, Dizavi A |
Asian Journal of Urology | 2022 |
|
Molecular mechanisms and therapeutic target of NETosis in diseases
Huang J, Hong W, Wan M, Zheng L |
2022 | |
|
Inflammatory-Metal Profile as a Hallmark for COVID-19 Severity During Pregnancy
Vásquez-Procopio J, Espejel-Nuñez A, Torres-Torres J, Martinez-Portilla RJ, Espino Y. Sosa S, Mateu-Rogell P, Ortega-Castillo V, Tolentino-Dolores M, Perichart-Perera O, Franco-Gallardo JO, Carranco-Martínez JA, Prieto-Rodríguez S, Guzmán-Huerta M, Missirlis F, Estrada-Gutierrez G |
Frontiers in Cell and Developmental Biology | 2022 |
|
Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection
Tayel SI, El-Masry EA, Abdelaal GA, Shehab-Eldeen S, Essa A, Muharram NM |
International journal of biological sciences | 2022 |
|
COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts
Välikangas T, Junttila S, Rytkönen KT, Kukkonen-Macchi A, Suomi T, Elo LL |
Frontiers in Genetics | 2022 |
|
ASSOCIATION OF TNF-α, TGF-β1, AMPHIREGULIN, IL-2, AND EGFR WITH PULMONARY FIBROSIS IN COVID-19
Maranatha D, Hasan H, Bakhtiar A, Widyoningroem A, Aryati |
Journal of Infection and Public Health | 2022 |
|
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
Perico N, Cortinovis M, Suter F, Remuzzi G |
The Lancet Infectious Diseases | 2022 |
|
Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
Khaswal A, Kumar V, Kumar S |
Diagnostics | 2022 |
|
Pregnancy-specific responses to COVID-19 are revealed by high-throughput proteomics of human plasma
Gomez-Lopez N, Romero R, Escobar MF, Carvajal JA, Echavarria MP, Albornoz LL, Nasner D, Miller D, Gallo DM, Galaz J, Arenas-Hernandez M, Bhatti G, Done B, Zambrano MA, Ramos I, Fernandez PA, Posada L, Chaiworapongsa T, Jung E, Garcia-Flores V, Suksai M, Gotsch F, Bosco M, Than NG, Tarca AL |
Research square | 2022 |
|
Human coronaviruses disassemble processing bodies
Kleer M, Mulloy RP, Robinson CA, Evseev D, Bui-Marinos MP, Castle EL, Banerjee A, Mubareka S, Mossman K, Corcoran JA |
PLoS pathogens | 2022 |
|
COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy
Khaledi M, Sameni F, Yahyazade S, Radandish M, Owlia P, Bagheri N, Afkhami H, Mahjoor M, Esmaelpour Z, Kohansal M, Aghaei F |
Frontiers in Medicine | 2022 |
|
Evaluating immunohaematological profile among COVID-19 active infection and recovered patients in Ghana
Konlaan Y, Asamoah Sakyi S, Kumi Asare K, Amoah Barnie P, Opoku S, Nakotey GK, Victor Nuvor S, Amoani B |
PloS one | 2022 |
|
Neutrophil-Lymphocyte Ratio Predicting Case Severity in SARS-CoV-2 Infection: A Review
Agarwal S |
Cureus | 2022 |
|
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
Potere N, Del Buono MG, Caricchio R, Cremer PC, Vecchié A, Porreca E, Dalla Gasperina D, Dentali F, Abbate A, Bonaventura A |
EBioMedicine | 2022 |
|
Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19
Li L, Wang X, Guo X, Li Y, Song Q, Li A |
Frontiers in pharmacology | 2022 |
|
Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients
Sánchez-de Prada L, Gorgojo-Galindo Ó, Fierro I, Martínez-García AM, de Quintana GS, Gutiérrez-Bustillo R, Pelaez-Jareño MT, Álvarez-Fuente E, Gómez-Sánchez E, Tamayo E, Tamayo-Velasco Á, Martín-Fernández M |
Frontiers in immunology | 2022 |
|
Fatal COVID-19 is Associated with Reduced HLA-DR, CD123 or CD11c Expression on Circulating Dendritic Cells
Hasan A, Al-Ozairi E, Hassan NY, Ali S, Ahmad R, Al-Shatti N, Alshemmari S, Al-Mulla F |
Journal of inflammation research | 2022 |
|
Functional consequences of SARS-CoV-2 infection in pregnant women, fetoplacental unit, and neonate
Carvajal J, Casanello P, Toso A, Farías M, Carrasco-Negue K, Araujo K, Valero P, Fuenzalida J, Solari C, Sobrevia L |
2022 | |
|
Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?-A Narrative Review.
Lorkiewicz P, Waszkiewicz N |
Journal of Clinical Medicine | 2022 |
|
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Nazerian Y, Ghasemi M, Yassaghi Y, Nazerian A, Hashemi SM |
International Immunopharmacology | 2022 |
|
Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A narrative review
Saikarthik J, Saraswathi I, Alarifi A, Al-Atram AA, Mickeymaray S, Paramasivam A, Shaikh S, Jeraud M, Alothaim AS |
PeerJ | 2022 |
|
Handheld, Low-Cost, Aptamer-Based Sensing Device for Rapid SARS-CoV-2 RNA Detection Using Novelly Synthesized Gold Nanoparticles
|
IEEE Sensors Journal | 2022 |
|
Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung
Miura Y, Ohkubo H, Nakano A, Bourke JE, Kanazawa S |
Frontiers in immunology | 2022 |
|
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses.
Venkataraman S |
Human vaccines | 2022 |
|
A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System
Abdelmissih S |
Cureus | 2022 |
|
Pathological Changes in the Lungs of Patients with a Lethal COVID-19 Clinical Course
Viksne V, Strumfa I, Sperga M, Ziemelis J, Abolins J |
Diagnostics | 2022 |
|
Association Between Guillain-Barré Syndrome and COVID-19 Infection: Experience of a Turkish Neurophysiology Laboratory
Durmaz ŞE, Kaya BU, Gümüşyayla Ş |
2022 | |
|
Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection prevention
Anderson CF, Wang Q, Stern D, Leonard EK, Sun B, Fergie KJ, Choi CY, Spangler JB, Villano J, Pekosz A, Brayton CF, Jia H, Cui H |
2022 | |
|
Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
Wang WX, Jia R, Song JW, Zhang X, Zhou SN, Wang FS, Fu J |
Frontiers in microbiology | 2022 |
|
SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
Zheng Q, Lin R, Chen Y, Lv Q, Zhang J, Zhai J, Xu W, Wang W |
Frontiers in immunology | 2022 |
|
Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists
Arai Y, Yamanaka I, Okamoto T, Isobe A, Nakai N, Kamimura N, Suzuki T, Daidoji T, Ono T, Nakaya T, Matsumoto K, Okuzaki D, Watanabe Y |
iScience | 2022 |
|
The Impact of COVID-19 Quarantine on Tuberculosis and Diabetes Mellitus Cases: A Modelling Study
Nuraini N, Fauzi IS, Lestari BW, Rizqina S |
Tropical Medicine and Infectious Disease | 2022 |
|
TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation
Kato Y, Nishiyama K, Man Lee J, Ibuki Y, Imai Y, Noda T, Kamiya N, Kusakabe T, Kanda Y, Nishida M |
International journal of molecular sciences | 2022 |
|
Molecular mechanisms implicated in SARS-CoV-2 liver tropism
Quarleri J, Delpino MV |
World Journal of Gastroenterology | 2022 |
|
Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions—Review of the Literature
Bucurica S, Ionita Radu F, Bucurica A, Socol C, Prodan I, Tudor I, Sirbu CA, Plesa FC, Jinga M |
Medicina | 2022 |
|
Assessment of commitment to healthy daily habits and diets, preventive measures, and beliefs about natural products utilization during COVID-19 pandemic in certain population in Egypt and Saudi Arabia
El-Malah A, Ibrahim TA, Attia H, Eid BG, Bagher AM, Binmahfouz LS, Sokkar NM |
Pharmacy Practice | 2022 |
|
HATCH Score for Predicting Mortality in COVID-19 Patients
Alıcı G, Genç Ö, Harbalıoğlu H, Başhir AM, Allahverdiyev S, Yıldırım A, Quisi A, Urgun ÖD, Kurt İH |
Iranian journal of public health | 2022 |
|
Polypropylene Modified with Ag-Based Semiconductors as a Potential Material against SARS-CoV-2 and Other Pathogens
Assis M, Ribeiro LK, Gonçalves MO, Staffa LH, Paiva RS, Lima LR, Coelho D, Almeida LF, Moraes LN, Rosa IL, Mascaro LH, Grotto RM, Sousa CP, Andrés J, Longo E, Cruz SA |
2022 | |
|
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath.
Chiang KC, Rizk JG, Nelson DJ, Krishnamurti L, Subbian S, Imig JD, Khan I, Reddy ST, Gupta A |
Expert Opinion on Therapeutic Targets | 2022 |
|
Efficacy of glucocorticoids, chloroquine and vitamin A on cytokine release syndrome: a network pharmacology study.
Zhang J, Zhu JJ, He SQ, Wang JX |
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan | 2022 |
|
Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA
Campbell GR, Rawat P, Spector SA |
Journal of Innate Immunity | 2022 |
|
Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study.
Küçük MP, Küçük AO, Pehlivanlar A, Mürtezaoğlu SA, Çoban K, Kılıç G, Ayçiçek O, Öztuna F, Bülbül Y, Özlü T |
2022 | |
|
IL-13 is a driver of COVID-19 severity
Alexandra N Donlan, Tara E Sutherland, Chelsea Marie, Saskia Preissner, Benjamin T. Bradley, Rebecca Carpenter, Jeffrey M. Sturek, Jennie Z. Ma, G. Brett Moreau, Jeffrey R Donowitz, Gregory A Buck, Myrna G Serrano, Stacey L Burgess, Mayuresh M Abhyankar, Cameron Mura, Philip E Bourne, Robert Preissner, Mary K Young, Genevieve R Lyons, Johanna J Loomba, Sarah J Ratcliffe, Melinda D Poulter, Amy J Mathers, Anthony J. Day, Barbara J Mann, Judith E. Allen, William A. Petri, Jr. |
JCI Insight | 2021 |
|
Nucleocapsid-specific and PD-L1+CXCR3+ CD8 polyfunctional T-cell abundances are associated with survival of critical SARS-CoV2-infected patients
Lucille Adam, Pierre Rosenbaum, Paul Quentric, Christophe Parizot, Olivia Bonduelle, Noëlline Guillou, Aurelien Corneau, Karim Dorgham, Makoto Miyara, Charles-Edouard Luyt, Amélie Guihot, Guy Gorochov, Christophe Combadière, Behazine Combadière |
JCI Insight | 2021 |
|
COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction
Kimberly A Queisser, Rebecca Mellema, Elizabeth A Middleton, Irina Portier, Bhanu Kanth Manne, Frederik Denorme, Ellen Beswick, Matthew Rondina, Robert Campbell, Aaron Petrey |
JCI Insight | 2021 |
|
Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19
G Zhao, Y Xu, J Li, X Cui, X Tan, H Zhang, L Dang |
Bioscience Reports | 2021 |
|
Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients
XN Zhao, Y You, XM Cui, HX Gao, GL Wang, SB Zhang, L Yao, LJ Duan, KL Zhu, YL Wang, L Li, JH Lu, HB Wang, JF Fan, HW Zheng, EH Dai, LY Tian, MJ Ma |
Signal Transduction and Targeted Therapy | 2021 |
|
Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases
M Elashiry, R Elsayed, MM Elashiry, MH Rashid, R Ara, AS Arbab, AR Elawady, M Hamrick, Y Liu, W Zhi, R Lucas, J Vazquez, CW Cutler |
Frontiers in immunology | 2021 |
|
Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation
H Englert, C Rangaswamy, C Deppermann, JP Sperhake, C Krisp, D Schreier, E Gordon, S Konrath, M Haddad, G Pula, RK Mailer, H Schlüter, S Kluge, F Langer, K Püschel, K Panousis, EX Stavrou, C Maas, T Renné, M Frye |
EBioMedicine | 2021 |
|
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
C Ruetsch, V Brglez, M Crémoni, K Zorzi, C Fernandez, S Boyer-Suavet, S Benzaken, E Demonchy, K Risso, J Courjon, E Cua, C Ichai, J Dellamonica, T Passeron, B Seitz-Polski |
Frontiers in Medicine | 2021 |
|
SARS‐CoV‐2 innate effector associations and viral load in early nasopharyngeal infection
TG Liou, FR Adler, BC Cahill, DR Cox, JE Cox, GJ Grant, KE Hanson, SC Hartsell, ND Hatton, MN Helms, JL Jensen, C Kartsonaki, Y Li, DT Leung, JE Marvin, EA Middleton, SM OsburnStaker, KA Packer, SM Shakir, AB Sturrock, KD Tardif, KJ Warren, LJ Waddoups, LJ Weaver, E Zimmerman, R Paine |
Physiological Reports | 2021 |
|
Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19
ID Toma, M Dierssen |
Scientific Reports | 2021 |
|
Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines
S Farhang-Sardroodi, C Korosec, S Gholami, M Craig, I Moyles, M Ghaemi, H Ooi, J Heffernan |
Human vaccines | 2021 |
|
Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response
L Pearce, SM Davidson, DM Yellon |
Basic Research in Cardiology | 2021 |
|
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
A Attiq, LJ Yao, S Afzal, MA Khan |
International Immunopharmacology | 2021 |
|
Comprehensive Landscape of Heparin Therapy for COVID-19
C Shi, W Tingting, JP Li, MA Sullivan, C Wang, H Wang, B Deng, Y Zhang |
Carbohydrate Polymers | 2021 |
|
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
A Banerjee, U Ganguly, S Saha, S Chakrabarti, RV Saini, RK Rawal, L Saso, S Chakrabarti |
Expert Review of Anti-infective Therapy | 2021 |
|
Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
A Kovalchuk, B Wang, D Li, R Rodriguez-Juarez, S Ilnytskyy, I Kovalchuk, O Kovalchuk |
Aging | 2021 |
|
Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review
M Izadi, L Cegolon, M Javanbakht, A Sarafzadeh, H Abolghasemi, G Alishiri, S Zhao, B Einollahi, M Kashaki, N Jonaidi-Jafari, M Asadi, R Jafari, S Fathi, H Nikoueinejad, M Ebrahimi, S Imanizadeh, AH Ghazale |
International Immunopharmacology | 2021 |
|
Inflammation, immunity and potential target therapy of SARS-COV-2: a total scale analysis review
SW Smail, M Saeed, T alkasalias, ZO Khudhur, DA Younus, MF Rajab, WH Abdulahad, HI Hussain, K Niaz, M Safdar |
Food and Chemical Toxicology | 2021 |
|
Cytokines: From Clinical Significance to Quantification
C Liu, D Chu, K KalantarZadeh, J George, HA Young, G Liu |
Advanced Science | 2021 |
|
Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2
SY Cheon, BN Koo |
International journal of molecular sciences | 2021 |
|
Repurposing Treatment of Wernicke–Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile
V Vatsalya, F Li, J Frimodig, KS Gala, S Srivastava, M Kong, VA Ramchandani, W Feng, X Zhang, CJ McClain |
Frontiers in pharmacology | 2021 |
|
Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
M Ghasemzadeh, A Ghasemzadeh, E Hosseini |
Human Immunology | 2021 |
|
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
MJ Dean, JB Ochoa, MD Sanchez-Pino, J Zabaleta, J Garai, LD Valle, D Wyczechowska, LB Baiamonte, P Philbrook, R Majumder, RS Heide, L Dunkenberger, RP Thylur, B Nossaman, WM Roberts, AG Chapple, J Wu, C Hicks, J Collins, B Luke, R Johnson, HK Koul, CA Rees, CR Morris, J Garcia-Diaz, AC Ochoa |
Frontiers in immunology | 2021 |
|
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
VJ Venditto, D Haydar, A Abdel-Latif, JC Gensel, MI Anstead, MG Pitts, J Creameans, TJ Kopper, C Peng, DJ Feola |
Frontiers in immunology | 2021 |
|
Cytokine Release Syndrome Associated with T-Cell-Based Therapies for Hematological Malignancies: Pathophysiology, Clinical Presentation, and Treatment
M Cosenza, S Sacchi, S Pozzi |
International journal of molecular sciences | 2021 |
|
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
SR Dyavar, R Singh, R Emani, GP Pawar, VD Chaudhari, AT Podany, SN Avedissian, CV Fletcher, DB Salunke |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
|
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
C Gillot, J Favresse, F Mullier, T Lecompte, JM Dogné, J Douxfils |
Frontiers in pharmacology | 2021 |
|
Characterization of low-density granulocytes in COVID-19
LE Cabrera, PT Pekkarinen, M Alander, KH Nowlan, NA Nguyen, S Jokiranta, S Kuivanen, A Patjas, S Mero, SH Pakkanen, S Heinonen, A Kantele, O Vapalahti, E Kekäläinen, T Strandin, MS Diamond |
PLoS pathogens | 2021 |
|
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
E Mortaz, P Tabarsi, H Jamaati, ND Roofchayee, NK Dezfuli, SM Hashemian, A Moniri, M Marjani, M Malekmohammad, D Mansouri, M Varahram, G Folkerts, IM Adcock |
Frontiers in immunology | 2021 |
|
Neutrophil Extracellular Traps and Their Implications in Cardiovascular and Inflammatory Disease
J Klopf, C Brostjan, W Eilenberg, C Neumayer |
International journal of molecular sciences | 2021 |
|
Cardiovascular Disease Complicating COVID-19 in the Elderly
C Dayaramani, JD Leon, AB Reiss |
Medicina | 2021 |
|
Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity
M Saichi, MZ Ladjemi, S Korniotis, C Rousseau, ZA Hamou, L Massenet-Regad, E Amblard, F Noel, Y Marie, D Bouteiller, J Medvedovic, F Pène, V Soumelis |
Nature Cell Biology | 2021 |
|
Climate change, environment pollution, COVID-19 pandemic and mental health
D Marazziti, P Cianconi, F Mucci, L Foresi, I Chiarantini, AD Vecchia |
The Science of The Total Environment | 2021 |
|
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
A Noce, M Albanese, G Marrone, MD Lauro, AP Zaitseva, D Palazzetti, C Guerriero, A Paolino, G Pizzenti, FD Daniele, A Romani, C DAgostini, A Magrini, NB Mercuri, ND Daniele |
Pharmaceuticals (Basel, Switzerland) | 2021 |
|
Vitamin D, zinc and glutamine: Synergistic action with OncoTherad immunomodulator in interferon signaling and COVID‑19 (Review)
J Name, A Vasconcelos, A Souza, W Fávaro |
International journal of molecular medicine | 2021 |
|
Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients
R Abu-Eid, FJ Ward |
Immunology Letters | 2021 |
|
Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis
I Vlodavsky, U Barash, H Nguyen, S Yang, N Ilan |
Seminars in thrombosis and hemostasis | 2021 |
|
A bird's eye view on the role of dendritic cells in SARS‐CoV‐2 infection: Perspectives for immune‐based vaccines
D Galati, S Zanotta, L Capitelli, M Bocchino |
Allergy | 2021 |
|
Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform
N Sa-nguanmoo, K Namdee, M Khongkow, U Ruktanonchai, YX Zhao, XJ Liang |
Nano research | 2021 |
|
Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
N Liu, C Jiang, P Cai, Z Shen, W Sun, H Xu, M Fang, X Yao, L Zhu, X Gao, J Fang, J Lin, C Guo, K Qu |
Cell Reports | 2021 |
|
Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm
YY Lee, HH Park, W Park, H Kim, JG Jang, KS Hong, JY Lee, HS Seo, DH Na, TH Kim, YB Choy, JH Ahn, W Lee, CG Park |
Biomaterials | 2021 |
|
Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
X Li, M Shao, X Zeng, P Qian, H Huang |
Signal Transduction and Targeted Therapy | 2021 |
|
COVID-19 Immunobiology: Lessons Learned, New Questions Arise
A Kaklamanos, K Belogiannis, P Skendros, VG Gorgoulis, PG Vlachoyiannopoulos, AG Tzioufas |
Frontiers in immunology | 2021 |
|
Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia
E Bloise, J Zhang, J Nakpu, H Hamada, CE Dunk, S Li, GE Imperio, L Nadeem, M Kibschull, P Lye, SG Matthews, SJ Lye |
American Journal of Obstetrics and Gynecology | 2021 |
|
Recent advances in materials science: a reinforced approach toward challenges against COVID-19
A Saxena, D Khare, S Agrawal, A Singh, AK Dubey |
2021 | |
|
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
J Huckriede, SB Anderberg, A Morales, F de Vries, M Hultström, A Bergqvist, JT Ortiz-Pérez, JW Sels, K Wichapong, M Lipcsey, M van de Poll, A Larsson, T Luther, C Reutelingsperger, PG de Frutos, R Frithiof, GA Nicolaes |
Scientific Reports | 2021 |
|
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients
M Olbei, I Hautefort, D Modos, A Treveil, M Poletti, L Gul, CD Shannon-Lowe, T Korcsmaros |
Frontiers in immunology | 2021 |
|
Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2
S Agrawal, J Salazar, TM Tran, A Agrawal |
Frontiers in immunology | 2021 |
|
The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge
Y Yan, W Zhou, Y Wang, Q Guo, F Zhao, Z Zhu, Y Xing, H Zhang, M Aljofan, AM Jarrahi, B Makabel, J Zhang |
Frontiers in Molecular Biosciences | 2021 |
|
Overview of the pathogenesis of COVID‑19 (Review)
C Li, Q He, H Qian, J Liu |
Experimental and therapeutic medicine | 2021 |
|
Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
S Gebremeskel, J Schanin, KM Coyle, M Butuci, T Luu, EC Brock, A Xu, A Wong, J Leung, W Korver, RD Morin, RP Schleimer, BS Bochner, BA Youngblood |
Frontiers in immunology | 2021 |
|
Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2
AB Islam, AA Khan, R Ahmed, S Hossain, ST Kabir, S Islam, AM Siddiki |
Journal of Translational Medicine | 2021 |
|
LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
B Combadière, L Adam, N Guillou, P Quentric, P Rosenbaum, K Dorgham, O Bonduelle, C Parizot, D Sauce, J Mayaux, CE Luyt, A Boissonnas, Z Amoura, V Pourcher, M Miyara, G Gorochov, A Guihot, C Combadière |
Frontiers in immunology | 2021 |
|
High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients
PA Penttilä, SV Gassen, D Panovska, L Vanderbeke, YV Herck, K Quintelier, A Emmaneel, J Filtjens, B Malengier-Devlies, K Ahmadzadeh, PV Mol, DM Borràs, A Antoranz, FM Bosisio, E Wauters, K Martinod, P Matthys, Y Saeys, AD Garg, J Wauters, FD Smet |
Cellular and Molecular Life Sciences | 2021 |
|
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
HK Lee, L Knabl, L Pipperger, A Volland, PA Furth, K Kang, HE Smith, L Knabl, R Bellmann, C Bernhard, N Kaiser, H Gänzer, M Ströhle, A Walser, D von Laer, L Hennighausen |
Scientific Reports | 2021 |
|
Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience
M Ruscica, C Macchi, S Iodice, G Tersalvi, I Rota, S Ghidini, L Terranova, L Valenti, F Amati, S Aliberti, A Corsini, F Blasi, S Carugo, V Bollati, M Vicenzi |
European Journal of Clinical Investigation | 2021 |
|
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
A Mazzoni, L Salvati, L Maggi, F Annunziato, L Cosmi |
Seminars in Immunology | 2021 |
|
Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
J Meng, Y Ma, J Jia, M Wang, J Teng, H Shi, H Liu, Y Su, J Ye, Y Sun, X Cheng, H Chi, T Liu, D Zhu, Z Zhou, L Wan, Z Wang, F Wang, X Qiao, X Chen, H Zhang, Z Tang, C Yang, Q Hu |
Frontiers in immunology | 2021 |
|
Potential Prophylactic Treatments for COVID-19
N Ben-Zuk, ID Dechtman, I Henn, L Weiss, A Afriat, E Krasner, Y Gal |
Viruses | 2021 |
|
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)
C Mussini, M Falcone, S Nozza, C Sagnelli, R Parrella, M Meschiari, N Petrosillo, C Mastroianni, A Cascio, C Iaria, M Galli, A Chirianni, E Sagnelli, C Iacobello, GD Perri, F Mazzotta, G Carosi, M Tinelli, P Grossi, O Armignacco, V Portelli, M Andreoni, M Tavio |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021 |
|
Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients
Q Chen, B Yu, Y Yang, J Huang, Y Liang, J Zhou, L Li, X Peng, B Cheng, Y Lin |
International Immunopharmacology | 2021 |
|
Clinical Relevance of Elevated Soluble ST2, HSP27 and 20S Proteasome at Hospital Admission in Patients with COVID-19
R Wendt, MT Lingitz, M Laggner, M Mildner, D Traxler, A Graf, P Krotka, B Moser, K Hoetzenecker, S Kalbitz, C Lübbert, J Beige, HJ Ankersmit |
Biology : open access journal | 2021 |
|
Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis
R Chu, C van Eeden, S Suresh, WI Sligl, M Osman, JW Tervaert |
International journal of molecular sciences | 2021 |
|
COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions
E Urano, T Okamura, C Ono, S Ueno, S Nagata, H Kamada, M Higuchi, M Furukawa, W Kamitani, Y Matsuura, Y Kawaoka, Y Yasutomi |
Proceedings of the National Academy of Sciences | 2021 |
|
Biomarkers of Post-COVID Depression
P Lorkiewicz, N Waszkiewicz |
Journal of Clinical Medicine | 2021 |
|
The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study
A Tanacan, N Yazihan, SA Erol, AT Anuk, FD Yetiskin, D Biriken, AS Ozgu-Erdinc, HL Keskin, OM Tekin, D Sahin |
Cytokine | 2021 |
|
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
AR Daamen, P Bachali, KA Owen, KM Kingsmore, EL Hubbard, AC Labonte, R Robl, S Shrotri, AC Grammer, PE Lipsky |
Scientific Reports | 2021 |
|
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics
N Hartog, W Faber, A Frisch, J Bauss, CP Bupp, S Rajasekaran, JW Prokop |
Expert Review of Proteomics | 2021 |
|
Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions
P Saha, S Bose, AK Srivastava, AA Chaudhary, R Lall, S Prasad |
Molecules (Basel, Switzerland) | 2021 |
|
COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology
MF Neurath |
Nature Reviews Gastroenterology & Hepatology | 2021 |
|
Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets
K Sriram, PA Insel |
Physiological reviews | 2021 |
|
Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review
J Pérez-Galarza, C Prócel, C Cañadas, D Aguirre, R Pibaque, R Bedón, F Sempértegui, H Drexhage, L Baldeón |
Human vaccines | 2021 |
|
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity
S Amin, S Aktar, M Rahman, MM Chowdhury |
Microbes and infection / Institut Pasteur | 2021 |
|
COVID-19 and fertility—at the crossroads of autoimmunity and thrombosis
J Tariq, T Chatterjee, L Andreoli, L Gupta |
Rheumatology International | 2021 |
|
Prognostic bioindicators in severe COVID-19 patients.
Bergantini L, Bargagli E, d'Alessandro M, Refini RM, Cameli P, Galasso L, Scapellato C, Montagnani F, Scolletta S, Franchi F, Valente S, Bennett D, Sebastiani G, Frediani B, Dotta F |
Cytokine | 2021 |
|
Montelukast in hospitalized patients diagnosed with COVID-19.
Khan AR, Misdary C, Yegya-Raman N, Kim S, Narayanan N, Siddiqui S, Salgame P, Radbel J, Groote F, Michel C, Mehnert J, Hernandez C, Braciale T, Malhotra J, Gentile MA, Jabbour SK |
Journal of Asthma | 2021 |
|
Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
Gao F, Zheng KI, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, Targher G, Byrne CD, George J, Zheng MH |
Frontiers in Endocrinology | 2021 |
|
From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling.
Castiglione F, Deb D, Srivastava AP, Liò P, Liso A |
Frontiers in immunology | 2021 |
|
Changes of Host Immunity Mediated by IFN-γ+ CD8+ T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness.
Zheng R, Li Y, Chen D, Su J, Han N, Chen H, Ning Z, Xiao M, Zhao M, Zhu B |
Viruses | 2021 |
|
Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans.
Rudd JM, Tamil Selvan M, Cowan S, Kao YF, Midkiff CC, Narayanan S, Ramachandran A, Ritchey JW, Miller CA |
Viruses | 2021 |
|
Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19.
Bodro M, Cofan F, Ríos J, Herrera S, Linares L, Marcos MA, Soriano A, Moreno A, Diekmann F |
Journal of Clinical Medicine | 2021 |
|
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
Lotfi R, Kalmarzi RN, Roghani SA |
Immunologic research | 2021 |
|
Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury.
Wang LL, Yang JW, Xu JF |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021 |
|
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
Ravindra NG, Alfajaro MM, Gasque V, Huston NC, Wan H, Szigeti-Buck K, Yasumoto Y, Greaney AM, Habet V, Chow RD, Chen JS, Wei J, Filler RB, Wang B, Wang G, Niklason LE, Montgomery RR, Eisenbarth SC, Chen S, Williams A, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, Pyle AM, van Dijk D, Wilen CB |
PLoS Biology | 2021 |
|
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.
Ansari S, Hays JP, Kemp A, Okechukwu R, Murugaiyan J, Ekwanzala MD, Ruiz Alvarez MJ, Paul-Satyaseela M, Iwu CD, Balleste-Delpierre C, Septimus E, Mugisha L, Fadare J, Chaudhuri S, Chibabhai V, Wadanamby JMRWW, Daoud Z, Xiao Y, Parkunan T, Khalaf Y, M'Ikanatha NM, van Dongen MBM |
2021 | |
|
Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report.
Hong X, He J, Li P, Chen J, Zou B, Li Z, Jia Y, Liu Y, Yang L, Li J |
Annals of translational medicine | 2021 |
|
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K |
Journal of molecular neuroscience : MN | 2021 |
|
When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.
Cappanera S, Palumbo M, Kwan SH, Priante G, Martella LA, Saraca LM, Sicari F, Vernelli C, Di Giuli C, Andreani P, Mariottini A, Francucci M, Sensi E, Costantini M, Bruzzone P, D'Andrea V, Gioia S, Cirocchi R, Tiri B |
Journal of Clinical Medicine | 2021 |
|
The Dynamic Expression of Potential Mediators of Severe Acute Respiratory Syndrome Coronavirus 2 Cellular Entry in Fetal, Neonatal, and Adult Rhesus Monkeys.
Cao B, Zhang L, Liu H, Ma S, Mi K |
Frontiers in Genetics | 2021 |
|
Predictive immunogenetic markers in COVID-19.
Leite MM, Gonzalez-Galarza FF, Silva BCCD, Middleton D, Santos EJMD |
Human Immunology | 2021 |
|
Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19.
Li T, Wang X, Zhuang X, Wang H, Li A, Huang L, Zhang X, Xue Y, Wei F, Ma C |
Internal and Emergency Medicine | 2021 |
|
Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature.
Munitz A, Edry-Botzer L, Itan M, Tur-Kaspa R, Dicker D, Marcoviciu D, Goren MG, Mor M, Lev S, Gottesman T, Muhsen K, Cohen D, Stein M, Qimron U, Freund NT, Wine Y, Gerlic M |
Scientific Reports | 2021 |
|
The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults.
Desai A, Caltagirone G, Sari S, Pocaterra D, Kogan M, Azzolini E, Savevski V, Martinelli-Boneschi F, Voza A, On Behalf Of The Humanitas Covid-Task Force |
Journal of Clinical Medicine | 2021 |
|
Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2.
Wolfe J, Safdar B, Madsen TE, Sethuraman KN, Becker B, Greenberg MR, McGregor AJ |
Clinical Therapeutics | 2021 |
|
A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital.
AlBahrani S, Al-Tawfiq JA, Alshaer AR, Shilash A, Alswefy K, Al-Zayer RS, Abouelela AM |
Journal of Epidemiology and Global Health | 2021 |
|
Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs.
Singh V, Beer A, Kraus A, Mang F, Zhang X, Xue J, Hagemann N, Hermann DM, Gunzer M |
Brain, Behavior, and Immunity | 2021 |
|
Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study.
Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M |
BMC neurology | 2021 |
|
Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
Ghosn L, Chaimani A, Evrenoglou T, Davidson M, Graña C, Schmucker C, Bollig C, Henschke N, Sguassero Y, Nejstgaard CH, Menon S, Nguyen TV, Ferrand G, Kapp P, Riveros C, Ávila C, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P, Boutron I |
The Cochrane Database of Systematic Reviews | 2021 |
|
A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19.
Zhang X, Gao R, Zhou Z, Tang X, Lin J, Wang L, Zhou X, Shen T |
International journal of medical sciences | 2021 |
|
[Histopathological features in fatal COVID-19 acute respiratory distress syndrome].
Merdji H, Mayeur S, Schenck M, Oulehri W, Clere-Jehl R, Cunat S, Herbrecht JE, Janssen-Langenstein R, Nicolae A, Helms J, Meziani F, Chenard MP |
Medicina Intensiva | 2021 |
|
BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome.
Pooladanda V, Thatikonda S, Muvvala SP, Devabattula G, Godugu C |
International Journal of Pharmaceutics | 2021 |
|
Health impact assessment of air pollutants during the COVID-19 pandemic in a Brazilian metropolis.
Leão MLP, Penteado JO, Ulguim SM, Gabriel RR, Dos Santos M, Brum AN, Zhang L, da Silva Júnior FMR |
Environmental Science and Pollution Research | 2021 |
|
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.
Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, Hernandez T, Stock A, Zhao Z, AlRasheed MR, Chen J, Li L, Wang D, Corben A, Haines GK 3rd, Westra WH, Umphlett M, Gordon RE, Reidy J, Petersen B, Salem F, Fiel MI, El Jamal SM, Tsankova NM, Houldsworth J, Mussa Z, Veremis B, Sordillo E, Gitman MR, Nowak M, Brody R, Harpaz N, Merad M, Gnjatic S, Liu WC, Schotsaert M, Miorin L, Aydillo Gomez TA, Ramos-Lopez I, Garcia-Sastre A, Donnelly R, Seigler P, Keys C, Cameron J, Moultrie I, Washington KL, Treatman J, Sebra R, Jhang J, Firpo A, Lednicky J, Paniz-Mondolfi A, Cordon-Cardo C, Fowkes ME |
Modern Pathology | 2021 |
|
Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report.
Kang K, Gao Y, Zhao M, Fei D, Ye M, Gao Y, Yang W, Wang C, Liu H, Chang G, Kang X, Luo Y, Du X, Qi J, Tian L, Zhou M, Hao C, Yu K |
Chinese Medical Journal | 2021 |
|
COVID-19 and Its Repercussions on Oral Health: A Review.
Rusu LC, Ardelean LC, Tigmeanu CV, Matichescu A, Sauciur I, Bratu EA |
2021 | |
|
A hydrated 2,3-diaminophenazinium chloride as a promising building block against SARS-CoV-2.
Mahato RK, Mahanty AK, Kotakonda M, Prasad S, Bhattacharyya S, Biswas B |
Scientific Reports | 2021 |
|
Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.
Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, Yuan W, Sun Z |
Frontiers in immunology | 2021 |
|
Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study.
Tong X, Cheng A, Yuan X, Zhong X, Wang H, Zhou W, Xu X, Li Y |
BMC Infectious Diseases | 2021 |
|
Targeting SARS-CoV-2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound.
Eid JI, Das B, Al-Tuwaijri MM, Basal WT |
Food Science & Nutrition | 2021 |
|
An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic.
Paula HSC, Santiago SB, Araújo LA, Pedroso CF, Marinho TA, Gonçalves IAJ, Santos TAP, Pinheiro RS, Oliveira GA, Batista KA |
2021 | |
|
Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and N-Acetylcysteine) Supplementation.
Kumar P, Osahon O, Vides DB, Hanania N, Minard CG, Sekhar RV |
2021 | |
|
Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients.
Touzot M, Lefebvre T, Maheas C, Peoc'h K, Ureña-Torres P, Ridel C, Puy H, Karim Z |
Clinical Kidney Journal | 2021 |
|
Reducing COVID-19 Cases and Deaths by Applying Blockchain in Vaccination Rollout Management.
Medina J, Cessa-Rojas R, Umpaichitra V |
2021 | |
|
Predictive hematological and immunological parameters associated with postpartum progressed Covid-19 disease.
Bozkurt F, Coskun O, Yelec S |
African health sciences | 2021 |
|
COVID-19-associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron.
Bouquegneau A, Erpicum P, Grosch S, Habran L, Hougrand O, Huart J, Krzesinski JM, Misset B, Hayette MP, Delvenne P, Bovy C, Kylies D, Huber TB, Puelles VG, Delanaye P, Jouret F |
2021 | |
|
IL-6 modulation for COVID-19: the right patients at the right time?
Ascierto PA, Fu B, Wei H |
Journal for ImmunoTherapy of Cancer | 2021 |
|
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis.
Alkhatip AAAMM, Kamel MG, Hamza MK, Farag EM, Yassin HM, Elayashy M, Naguib AA, Wagih M, Abd-Elhay FA, Algameel HZ, Yousef MA, Purcell A, Helmy M |
Expert Review of Molecular Diagnostics | 2021 |
|
COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients?
Perico N, Perico L, Ronco C, Remuzzi G |
Contributions to nephrology | 2021 |
|
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon
Hasselbalch HC, Skov V, Kjær L, Ellervik C, Poulsen A, Poulsen TD, Nielsen CH |
Cytokine & Growth Factor Reviews | 2021 |
|
Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.
Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA |
Neurocritical Care | 2021 |
|
Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
Pinky, Gupta S, Krishnakumar V, Sharma Y, Dinda AK, Mohanty S |
Stem Cell Reviews and Reports | 2021 |
|
COVID-19: An Update on the Epidemiological, Clinical, Preventive, and Therapeutic Management of 2019 Novel Coronavirus Disease.
Ashraf O, Virani A, Cheema T |
Critical Care Nursing Quarterly | 2021 |
|
The relationship between COVID-19 and the dental damage stage determined by radiological examination.
Sirin DA, Ozcelik F |
Oral Radiology | 2021 |
|
Risk factors related to the severity of COVID-19 in Wuhan.
Zhao C, Bai Y, Wang C, Zhong Y, Lu N, Tian L, Cai F, Jin R |
International journal of medical sciences | 2021 |
|
Pharmacotherapeutics of SARS-CoV-2 Infections.
Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, Soni D, Das S, Hasan M, Patel M, Senan AM, Gorantla S, McMillan J, Edagwa B, Eisenberg R, Gurumurthy CB, Reid SPM, Punyadeera C, Chang L, Gendelman HE |
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2021 |
|
CRISPR systems: Novel approaches for detection and combating COVID-19.
Safari F, Afarid M, Rastegari B, Borhani-Haghighi A, Barekati-Mowahed M, Behzad-Behbahani A |
Virus Research | 2021 |
|
Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
Terracciano R, Preianò M, Fregola A, Pelaia C, Montalcini T, Savino R |
International journal of molecular sciences | 2021 |
|
Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19.
An YW, Yuan B, Wang JC, Wang C, Liu TT, Song S, Liu HQ |
International journal of medical sciences | 2021 |
|
On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.
Földvári-Nagy L, Schnabel T, Dörnyei G, Korcsmáros T, Lenti K |
Cell communication and signaling : CCS | 2021 |
|
A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations.
Krishnan A, Hamilton JP, Alqahtani SA, A Woreta T |
Internal and Emergency Medicine | 2021 |
|
SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient.
Rizzo R, Neri LM, Simioni C, Bortolotti D, Occhionorelli S, Zauli G, Secchiero P, Semprini CM, Laface I, Sanz JM, Lanza G, Gafà R, Passaro A |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021 |
|
Cardiovascular Complications of COVID-19 and Associated Concerns: A Review.
Yu WL, Toh HS, Liao CT, Chang WT |
2021 | |
|
Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020.
Richez C, Flipo RM, Berenbaum F, Cantagrel A, Claudepierre P, Debiais F, Dieudé P, Goupille P, Roux C, Schaeverbeke T, Wendling D, Pham T, Thomas T |
Revue du rhumatisme (Ed. francaise : 1993) | 2021 |
|
Comments on potential re-purposing of medicines against high-altitude illnesses towards SARS-CoV2: possibilities and pitfalls.
Ahmad Y, Paul S, Varshney R, Kumar B |
2021 | |
|
Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.
Choudhary J, Dheeman S, Sharma V, Katiyar P, Karn SK, Sarangi MK, Chauhan AK, Verma G, Baliyan N |
Biological Procedures Online | 2021 |
|
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.
Wu YH, Yeh IJ, Phan NN, Yen MC, Liu HL, Wang CY, Hsu HP |
International journal of medical sciences | 2021 |
|
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra.
Mortaz E, Bassir A, Dalil Roofchayee N, Dezfuli NK, Jamaati H, Tabarsi P, Moniri A, Rezaei M, Mehrian P, Varahram M, Marjani M, Mumby S, Adcock IM |
International Immunopharmacology | 2021 |
|
Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines.
Villena J, Li C, Vizoso-Pinto MG, Sacur J, Ren L, Kitazawa H |
Microorganisms | 2021 |
|
Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a Predominantly African American Cohort.
Hayek ME, Mansour M, Ndetan H, Burkes Q, Corkern R, Dulli A, Hayek R, Parvez K, Singh S |
2021 | |
|
Thymidine Phosphorylase Is Increased in COVID-19 Patients in an Acuity-Dependent Manner.
Li W, Yue H |
Frontiers in Medicine | 2021 |
|
Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.
Gruca A, Ziemska-Legiecka J, Jarnot P, Sarnowska E, Sarnowski TJ, Grynberg M |
BMC bioinformatics | 2021 |
|
COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies.
Haybar H, Maniati M, Saki N, Zayeri ZD |
Molecular Biology Reports | 2021 |
|
Hemogram as marker of in-hospital mortality in COVID-19.
López-Escobar A, Madurga R, Castellano JM, Ruiz de Aguiar S, Velázquez S, Bucar M, Jimeno S, Ventura PS |
Journal of investigative medicine : the official publication of the American Federation for Clinical Research | 2021 |
|
Molecular optimization, docking, and dynamic simulation profiling of selective aromatic phytochemical ligands in blocking the SARS-CoV-2 S protein attachment to ACE2 receptor: an in silico approach of targeted drug designing.
Dey D, Paul PK, Al Azad S, Al Mazid MF, Khan AM, Sharif MA, Rahman MH |
2021 | |
|
Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment.
Qian J, Xu H, Lv D, Liu W, Chen E, Zhou Y, Wang Y, Ying K, Fan X |
Biomedicine & Pharmacotherapy | 2021 |
|
Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections.
McReynolds CB, Cortes-Puch I, Ravindran R, Khan IH, Hammock BG, Shih PB, Hammock BD, Yang J |
Frontiers in physiology | 2021 |
|
A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway.
Reyes-Lagos JJ, Abarca-Castro EA, Echeverría JC, Mendieta-Zerón H, Vargas-Caraveo A, Pacheco-López G |
Frontiers in psychology | 2021 |
|
Immunological Interfaces: The COVID-19 Pandemic and Depression.
Perlmutter A |
Frontiers in neurology | 2021 |
|
Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside.
Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, Makvandi P |
ACS Biomaterials Science & Engineering | 2021 |
|
Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illness.
Felix JC, Sheinin YM, Suster D, Ronen N, Ratiani M, Vanden Heuvel T, Winge E, Patton MD, Rau MJ, Ge L, Sun Y, Udhane SS, Langenheim JF, Rui H |
Annals of Diagnostic Pathology | 2021 |
|
Emerging role of air pollution and meteorological parameters in COVID-19.
Zhao C, Fang X, Feng Y, Fang X, He J, Pan H |
Journal of Evidence-Based Medicine | 2021 |
|
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19.
Wei F, Kong D, Li T, Li A, Tan Y, Fang J, Zhuang X, Lai C, Xu W, Dong H, Ma C, Hong K, Cui Y, Tang S, Yu F, Zheng C |
2021 | |
|
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication.
Tu WJ, McCuaig RD, Melino M, Rawle DJ, Le TT, Yan K, Suhrbier A, Johnston RL, Koufariotis LT, Waddell N, Cross EM, Tsimbalyuk S, Bain A, Ahern E, Collinson N, Phipps S, Forwood JK, Seddiki N, Rao S |
Cell Discovery | 2021 |
|
Distinct Coagulopathy With Myocardial Injury and Pulmonary Embolism in COVID-19.
Fath AR, Aglan A, Varkoly KS, Eldaly AS, Beladi RN, Forlemu A, Mihyawi N, Solsi A, Israr S, Lucas AR |
Journal of Investigative Medicine High Impact Case Reports | 2021 |
|
Exosomes contribution in COVID-19 patients' treatment.
Mazini L, Rochette L, Malka G |
Journal of Translational Medicine | 2021 |
|
Histopathological features in fatal COVID-19 acute respiratory distress syndrome.
Merdji H, Mayeur S, Schenck M, Oulehri W, Clere-Jehl R, Cunat S, Herbrecht JE, Janssen-Langenstein R, Nicolae A, Helms J, Meziani F, Chenard MP |
Medicina Intensiva | 2021 |
|
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study.
Conte C, Esposito A, De Lorenzo R, Di Filippo L, Palmisano A, Vignale D, Leone R, Nicoletti V, Ruggeri A, Gallone G, Secchi A, Bosi E, Tresoldi M, Castagna A, Landoni G, Zangrillo A, De Cobelli F, Ciceri F, Camici P, Rovere-Querini P |
Nutrition, Metabolism, and Cardiovascular Diseases | 2021 |
|
Laboratory tests for the detection of SARS-CoV-2 infection: basic principles and examples.
Alkharsah KR |
German medical science : GMS e-journal | 2021 |
|
Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study.
Beeckmans S, Van Driessche E |
Frontiers in Molecular Biosciences | 2021 |
|
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s).
Mohanty S, Paul S, Ahmad Y |
VirusDisease | 2021 |
|
The role of SARC-F scale in predicting progression risk of COVID-19 in elderly patients: a prospective cohort study in Wuhan.
Ma Y, He M, Hou LS, Xu S, Huang ZX, Zhao N, Kang Y, Yue JR, Wu C |
BMC geriatrics | 2021 |
|
Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
Du F, Sun W, Morisseau C, Hammock BD, Bao X, Liu Q, Wang C, Zhang T, Yang H, Zhou J, Xiao W, Liu Z, Chen G |
European Journal of Medicinal Chemistry | 2021 |
|
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.
Satsangi S, Gupta N, Kodan P |
Journal of Clinical and Translational Hepatology | 2021 |
|
Sphingolipids as Modulators of SARS-CoV-2 Infection.
Törnquist K, Asghar MY, Srinivasan V, Korhonen L, Lindholm D |
Frontiers in Cell and Developmental Biology | 2021 |
|
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy.
Brimson JM, Prasanth MI, Malar DS, Brimson S, Thitilertdecha P, Tencomnao T |
Expert Opinion on Therapeutic Targets | 2021 |
|
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
Aksakal A, Kerget B, Kerget F, Aşkın S |
Journal of Medical Virology | 2021 |
|
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis.
McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L |
2021 | |
|
Frailty Pathogenesis, Assessment, and Management in Older Adults With COVID-19.
She Q, Chen B, Liu W, Li M, Zhao W, Wu J |
Frontiers in Medicine | 2021 |
|
Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients.
Karina K, Rosliana I, Rosadi I, Sobariah S, Christoffel LM, Novariani R, Rosidah S, Fatkhurohman N, Hertati Y, Puspitaningrum N, Subroto WR, Afini I, Ernanda D |
International Journal of Inflammation | 2021 |
|
Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19.
Wang L, Wang Y, Yang W, He X, Xu S, Liu X, He Y, Hu Q, Yuan D, Jin T |
Journal of Medical Microbiology | 2021 |
|
An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.
Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ |
iScience | 2021 |
|
Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and case fatality rate.
Accinelli RA, Ynga-Meléndez GJ, León-Abarca JA, López LM, Madrid-Cisneros JC, Mendoza-Saldaña JD |
Travel Medicine and Infectious Disease | 2021 |
|
Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19.
Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S |
Comparative Clinical Pathology | 2021 |
|
Broad antiviral and anti-inflammatory efficacy of nafamostat against SARS-CoV-2 and seasonal coronaviruses in primary human bronchiolar epithelia.
Niemeyer BF, Miller CM, Ledesma-Feliciano C, Morrison JH, Jimenez-Valdes R, Clifton C, Poeschla EM, Benam KH |
2021 | |
|
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.
Cordeiro A, Ribamar A, Ramalho A |
Clinics and Research in Hepatology and Gastroenterology | 2021 |
|
Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection.
Paulsson-Habegger L, Snabaitis AK, Wren SP |
Bioorganic & Medicinal Chemistry | 2021 |
|
Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution.
Hassan SS, Basu P, Redwan EM, Lundstrom K, Choudhury PP, Serrano-Aroca Á, Azad GK, Aljabali AAA, Palu G, Abd El-Aziz TM, Barh D, Uhal BD, Adadi P, Takayama K, Bazan NG, Tambuwala MM, Lal A, Chauhan G, Baetas-da-Cruz W, Sherchan SP, Uversky VN |
Environmental Research | 2021 |
|
Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force microscopy.
Abrego-Martinez JC, Jafari M, Chergui S, Pavel C, Che D, Siaj M |
Biosensors & bioelectronics | 2021 |
|
Clinical Evidences and Pathophysiology of Cardiac Arrhythmia in the Era of Coronavirus Disease-2019.
Hamad AKS |
Heart views : the official journal of the Gulf Heart Association | 2021 |
|
Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device.
Jagannath B, Lin KC, Pali M, Sankhala D, Muthukumar S, Prasad S |
Bioengineering & Translational Medicine | 2021 |
|
A Mid-to-Long Term Comprehensive Evaluation of Psychological Distress and Erectile Function in COVID-19 Recovered Patients.
Hu B, Ruan Y, Liu K, Wei X, Wu Y, Feng H, Deng Z, Liu J, Wang T |
The Journal of Sexual Medicine | 2021 |
|
COVID-19 & Sociocultural Determinants of Global Sanitation: An Aide-Mémoire and Call to Decolonize Global Sanitation Research & Practice.
Irfan A, St Jean DT |
Annals of Global Health | 2021 |
|
Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals.
Vargas-Mendoza N, García-Machorro J, Angeles-Valencia M, Martínez-Archundia M, Madrigal-Santillán EO, Morales-González Á, Anguiano-Robledo L, Morales-González JA |
World Journal of Gastroenterology | 2021 |
|
Liver disease in the era of COVID-19: Is the worst yet to come?
Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S |
World Journal of Gastroenterology | 2021 |
|
Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic.
Jain S, Venkataraman A, Wechsler ME, Peppas NA |
Advanced Drug Delivery Reviews | 2021 |
|
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios.
Palandri F, Breccia M, De Stefano V, Passamonti F |
Cancers | 2021 |
|
Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity.
Chen S, Evert B, Adeniyi A, Salla-Martret M, Lua LH, Ozberk V, Pandey M, Good MF, Suhrbier A, Halfmann P, Kawaoka Y, Rehm BHA |
Advanced Healthcare Materials | 2021 |
|
Impact of COVID-19 Infection on Quality of Sleep.
Choudhry AA, Shahzeen F, Choudhry SA, Batool N, Murtaza F, Dilip A, Rani M, Chandnani A |
Cureus | 2021 |
|
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence.
Idalsoaga F, Ayares G, Arab JP, Díaz LA |
Journal of Clinical and Translational Hepatology | 2021 |
|
Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.
Jia F, Wang G, Xu J, Long J, Deng F, Jiang W |
Aging | 2021 |
|
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study.
Singh Y, Singh A, Rudravaram S, Soni KD, Aggarwal R, Patel N, Wig N, Trikha A |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2021 |
|
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.
D'Antonio M, Nguyen JP, Arthur TD, Matsui H, D'Antonio-Chronowska A, Frazer KA |
Cell Reports | 2021 |
|
Hypercoagulability of COVID-19 and Neurological Complications: A Review.
Moore P, Esmail F, Qin S, Nand S, Berg S |
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2021 |
|
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19.
Ni Y, Alu A, Lei H, Wang Y, Wu M, Wei X |
2021 | |
|
Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
Sukrisman L, Sinto R |
2021 | |
|
COVID-19 Infection Is Associated With New Onset Erectile Dysfunction: Insights From a National Registry.
Chu KY, Nackeeran S, Horodyski L, Masterson TA, Ramasamy R |
Sexual Medicine | 2021 |
|
The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers.
Sansone A, Mollaioli D, Limoncin E, Ciocca G, Bắc NH, Cao TN, Hou G, Yuan J, Zitzmann M, Giraldi A, Jannini EA |
Sexual Medicine Reviews | 2021 |
|
Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.
Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D |
Scandinavian Journal of Immunology | 2021 |
|
Increased Kynurenine Indicates a Fatal Course of COVID-19.
Mangge H, Herrmann M, Meinitzer A, Pailer S, Curcic P, Sloup Z, Holter M, Prüller F |
2021 | |
|
Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
Kim N, Lee JM, Oh EJ, Jekarl DW, Lee DG, Im KI, Cho SG |
Frontiers in immunology | 2021 |
|
Disseminated Intravascular Coagulation Score and Sepsis-induced Coagulopathy Score in Prediction of COVID-19 Severity: A Retrospective Analysis.
Kapoor M, Panda PK, Saini LK, Bahurupi Y |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2021 |
|
Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies.
Joseph S, Kutty Narayanan A |
Advanced pharmaceutical bulletin | 2021 |
|
Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Single-Center Study.
Karras A, Livrozet M, Lazareth H, Benichou N, Hulot JS, Fayol A, Chauvet S, Jannot AS, Penet MA, Diehl JL, Godier A, Sanchez O, Mirault T, Thervet E, Pallet N |
Clinical journal of the American Society of Nephrology : CJASN | 2021 |
|
Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
Pal D |
Journal of Structural Biology | 2021 |
|
Coagulopathy in COVID-19.
Lio KU, Rali P |
Lung India : official organ of Indian Chest Society | 2021 |
|
Perspectives on COVID-19 and cancer immunotherapy: a review series.
Goldman JD, Ascierto PA |
Journal for ImmunoTherapy of Cancer | 2021 |
|
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.
Campbell GR, To RK, Hanna J, Spector SA |
iScience | 2021 |
|
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.
Koenecke A, Powell M, Xiong R, Shen Z, Fischer N, Huq S, Khalafallah AM, Trevisan M, Sparen P, Carrero JJ, Nishimura A, Caffo B, Stuart EA, Bai R, Staedtke V, Thomas DL, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S, Bettegowda C, Konig MF, Mensh BD, Vogelstein JT, Athey S |
eLife | 2021 |
|
Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.
Niles MA, Gogesch P, Kronhart S, Ortega Iannazzo S, Kochs G, Waibler Z, Anzaghe M |
Frontiers in immunology | 2021 |
|
Analysis of the Efficacy and Mechanism of Action of Xuebijing Injection on ARDS Using Meta-Analysis and Network Pharmacology.
Zhang Y, Wang J, Liu YM, Yang H, Wu GJ, He XH |
BioMed Research International | 2021 |
|
COVID-19: Where is the treatment?
Sabeerabi B, Vemula S, Vadde R, Nagaraju GP |
World journal of clinical oncology | 2021 |
|
ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea.
Pham TL, He J, Kakazu AH, Calandria J, Do KV, Nshimiyimana R, Lam TF, Petasis NA, Bazan HEP, Bazan NG |
Scientific Reports | 2021 |
|
COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications.
Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, Dewanjee S, Kandimalla R |
Frontiers in aging neuroscience | 2021 |
|
What Has Changed in the Treatment of Psoriatic Arthritis After COVID-19?
Keskin Y, Koz G, Nas K |
The Eurasian Journal of Medicine | 2021 |
|
Correlation Between Anosmia and Severity Along with Requirement of Tocilizumab in COVID-19 Patients.
Silu M, Mathur NP, Kumari R, Chaudhary P |
2021 | |
|
Surveillance of hemorrhagic fever and/or neuroinvasive disease: challenges of diagnosis.
Araújo LJT, Gonzalez LL, Buss LF, Guerra JM, Gomez DS, Ferreira CSDS, Cirqueira CS, Ghillardi F, Witkin SS, Sabino EC |
2021 | |
|
Superinfections in COVID-19 Patients: Role of Antimicrobials
Nag VL, Kaur N |
2021 | |
|
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India
Dravid A, Kashiva R, Khan Z, Memon D, Kodre A, Potdar P, Mane M, Borse R, Pawar V, Patil D, Banerjee D, Bhoite K, Pharande R, Kalyani S, Raut P, Bapte M, Mehta A, Reddy MS, Bhayani K, Laxmi SS, Vishnu PD, Srivastava S, Khandelwal S, More S, Shinde R, Pawar M, Harshe A, Kadam S, Mahajan U, Joshi G, Mane D |
Medicine | 2021 |
|
Cytokine-Induced Modulation of SARS-CoV2 Receptor Expression in Primary Human Nasal Epithelial Cells
Ramezanpour M, Bolt H, Hon K, Bouras GS, Psaltis AJ, Wormald PJ, Vreugde S |
Pathogens | 2021 |
|
Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19
Velazquez S, Madurga R, Castellano JM, Rodriguez-Pascual J, de Aguiar Diaz Obregon SR, Jimeno S, Montero JI, Wichner PS, López-Escobar A |
BMC emergency medicine | 2021 |
|
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Park JG, Oladunni FS, Rohaim MA, Whittingham-Dowd J, Tollitt J, Hodges MD, Fathallah N, Assas MB, Alhazmi W, Almilaibary A, Iqbal M, Chang P, Escalona R, Shivanna V, Torrelles JB, Worthington JJ, Jackson-Jones LH, Martinez-Sobrido L, Munir M |
iScience | 2021 |
|
A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
He B, Hou F, Ren C, Bing P, Xiao X |
Frontiers in Oncology | 2021 |
|
Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
Abdullah S, Bashir N, Mahmood N |
Journal of medical case reports | 2021 |
|
COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges
Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K |
World journal of clinical cases | 2021 |
|
Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2
Yang SJ, Wei TC, Hsu CH, Ho SN, Lai CY, Huang SF, Chen YY, Liu SJ, Yu GY, Dou HY |
Journal of inflammation research | 2021 |
|
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation
Mazzariol A, Benini A, Unali I, Nocini R, Smania M, Bertoncelli A, De Sanctis F, Ugel S, Donadello K, Polati E, Gibellini D |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
Incorrect Facemask-Wearing Detection Using Convolutional Neural Networks with Transfer Learning
Tomás J, Rego A, Viciano-Tudela S, Lloret J |
Healthcare | 2021 |
|
Immunomodulation and immunotherapeutics of COVID-19
Garg SS, Sharma A, Gupta J |
Clinical Immunology | 2021 |
|
SARS-CoV-2 infection of the central nervous system in a 14-month-old child: A case report of a complete autopsy
Gomes I, Karmirian K, Oliveira JT, Pedrosa CD, Mendes MA, Rosman FC, Chimelli L, Rehen S |
2021 | |
|
A 50-Year-Old Patient with Guillain–Barré Syndrome after COVID-19: A Case Report
Chmiela T, Rzepka M, Krzystanek E, Gorzkowska A |
Medicina | 2021 |
|
The effectiveness of early colchicine administration in patients over 60 years old with high risk of developing severe pulmonary complications associated with coronavirus pneumonia SARS-CoV-2 (COVID-19): study protocol for an investigator-driven randomized controlled clinical trial in primary health care—COLCHICOVID study
Estebanez EB, Alconero LL, Fernández BJ, Marguello MG, Caro JC, Vallejo JD, Sampedro MF, Cacho PM, Espiga CR, Saiz MM |
Trials | 2021 |
|
Pathophysiologie von COVID-19 und deren mögliche Bedeutung für Long-COVID
Scherr J |
2021 | |
|
Traitements systémiques et risque infectieux dans le contexte de pandémie COVID-19: Systemic treatments and infection risk in the context of the COVID-19 pandemic
Villani AP |
2021 | |
|
SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells
Jiang M, Kolehmainen P, Kakkola L, Maljanen S, Melén K, Smura T, Julkunen I, Österlund P |
Microbiology spectrum | 2021 |
|
Obésité et Covid-19
Clément K, Le Lay S |
2021 | |
|
A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseases
Scott TM, Jensen S, Pickett BE |
F1000Research | 2021 |
|
Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
Kuznik B, Khavinson V, Shapovalov K, Linkova N, Lukyanov S, Smolyakov Y, Tereshkov P, Shapovalov Y, Konnov V, Tsybikov N |
Advances in Gerontology | 2021 |
|
Mesenchymal Stem Cells in the Treatment of New Coronavirus Pandemic: A Novel Promising Therapeutic Approach
Razi S, Molavi Z, Mirmotalebisohi SA, Niknam Z, Sameni M, Niazi V, Adibi A, Yazdani M, Ranjbar MM, Zali H |
Advanced pharmaceutical bulletin | 2021 |
|
Case Report and Literature Review: COVID-19 and status epilepticus in Dyke-Davidoff-Masson syndrome
Ibañez Valdés LD, Geroge J, Joseph S, Alshmandi M, Makaleni W, Foyaca Sibat H |
F1000Research | 2021 |
|
Immunomodulatory activity of β-glucan polysaccharides isolated from different species of mushroom - A potential treatment for inflammatory lung conditions.
Murphy EJ, Rezoagli E, Pogue R, Simonassi-Paiva B, Abidin IIZ, Fehrenbach GW, O'Neil E, Major I, Laffey JG, Rowan N |
The Science of The Total Environment | 2021 |
|
Knowledge and attitude of dental professionals toward COVID-19 in Riyadh, Saudi Arabia: a cross-sectional survey
Divakar DD, Nimbeni SB, Al-Kheraif AA, Khan AA, Naik S, Khanagar SB, Jhugroo C, Nimbeni B |
2021 | |
|
IL-13 is a driver of COVID-19 severity.
Donlan AN, Sutherland TE, Marie C, Preissner S, Bradley BT, Carpenter RM, Sturek JM, Ma JZ, Moreau GB, Donowitz JR, Buck GA, Serrano MG, Burgess SL, Abhyankar MM, Mura C, Bourne PE, Preissner R, Young MK, Lyons GR, Loomba JJ, Ratcliffe SJ, Poulter MD, Mathers AJ, Day A, Mann BJ, Allen JE, Petri WA Jr |
medRxiv : the preprint server for health sciences | 2021 |
|
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents.
Zarkoob H, Allué-Guardia A, Chen YC, Jung O, Garcia-Vilanova A, Song MJ, Park JG, Oladunni F, Miller J, Tung YT, Kosik I, Schultz D, Yewdell J, Torrelles JB, Martinez-Sobrido L, Cherry S, Ferrer M, Lee EM |
bioRxiv : the preprint server for biology | 2021 |
|
Insights into genetic factors contributing to variability in SARS-CoV-2 susceptibility and COVID-19 disease severity.
D'Antonio M, Arthur TD, Nguyen JP, Matsui H, D'Antonio-Chronowska A, Frazer KA |
medRxiv : the preprint server for health sciences | 2021 |
|
Systematic temporal analysis of peripheral blood transcriptomes using TrendCatcher identifies early and persistent neutrophil activation as a hallmark of severe COVID-19
Wang X, Sanborn M, Dai Y, Rehman J |
2021 | |
|
COVID-19 Subclinical Infection and Immunity: A Review
Bartekwa JW, Abene EE, Luka PD, Yilgwan CS, Shehu NY |
2021 | |
|
Clinicopathologic features of a feline SARS-CoV-2 infection model parallel acute COVID-19 in humans
Rudd JM, Selvan MT, Cowan S, Kao YF, Midkiff CC, Ritchey JW, Miller CA |
2021 | |
|
Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal
Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ |
2021 | |
|
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, Travis Nemkov, Lorenzo Bertolone, Richard O. Francis, Krystalyn E. Hudson, James C. Zimring, Kirk C. Hansen, Eldad A. Hod, Steven L. Spitalnik, Angelo D’Alessandro |
JCI Insight | 2020 |
|
The Complement System in COVID-19: Friend and Foe?
Anuja Java, Anthony J. Apicelli, M. Kathryn Liszewski, Ariella Coler-Reilly, John P. Atkinson, Alfred H.J. Kim, Hrishikesh S. Kulkarni |
JCI Insight | 2020 |
|
Neutrophil extracellular traps in COVID-19
Yu Zuo, Srilakshmi Yalavarthi, Hui Shi, Kelsey Gockman, Melanie Zuo, Jacqueline A. Madison, Christopher N. Blair, Andrew Weber, Betsy J. Barnes, Mikala Egeblad, Robert J. Woods, Yogendra Kanthi, Jason S. Knight |
JCI Insight | 2020 |
|
The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study
C Shi, C Wang, H Wang, C Yang, F Cai, F Zeng, F Cheng, Y Liu, T Zhou, B Deng, I Vlodavsky, JP Li, Y Zhang |
Clinical and Translational Science | 2020 |
|
Measurement of Cellular Immune Response to Viral Infection and Vaccination
W Bouwman, W Verhaegh, L Holtzer, A van de Stolpe |
Frontiers in immunology | 2020 |
|
Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response
J Demaret, G Lefèvre, F Vuotto, J Trauet, A Duhamel, J Labreuche, P Varlet, A Dendooven, S Stabler, B Gachet, J Bauer, B Prevost, L Bocket, EK Alidjinou, M Lambert, C Yelnik, B Meresse, L Dubuquoy, D Launay, S Dubucquoi, D Montaigne, E Woitrain, F Maggiotto, MB Saleh, I Top, V Elsermans, E Jeanpierre, A Dupont, S Susen, T Brousseau, J Poissy, K Faure, M Labalette |
IBMS BoneKEy | 2020 |
|
Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis
X Dong, C Wang, X Liu, W Gao, X Bai, Z Li |
Frontiers in immunology | 2020 |
|
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
G Morris, CC Bortolasci, BK Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk |
Life Sciences | 2020 |
|
Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines
Y Xiao, H Xu, W Guo, Y Zhao, Y Luo, M Wang, Z He, Z Ding, J Liu, L Deng, F Sha, X Ma |
2020 | |
|
The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2
JA Collora, R Liu, K Albrecht, YC Ho |
Current Opinion in HIV and AIDS | 2020 |
|
Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis
P Ahluwalia, M Ahluwalia, K Vaibhav, A Mondal, N Sahajpal, S Islam, S Fulzele, V Kota, K Dhandapani, B Baban, AM Rojiani, R Kolhe |
The EPMA Journal | 2020 |
|
The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
GM Ellison-Hughes, L Colley, KA O'Brien, KA Roberts, TA Agbaedeng, MD Ross |
Frontiers in Cardiovascular Medicine | 2020 |
|
The Use of Non‐invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID ‐19: A Theoretical Hypothesis and Early Clinical Experience
P Staats, G Giannakopoulos, J Blake, E Liebler, RM Levy |
Neuromodulation Technology at the Neural Interface | 2020 |
|
Cytokine storm syndrome in severe COVID-19
P Ruscitti, O Berardicurti, A Iagnocco, R Giacomelli |
Autoimmunity Reviews | 2020 |
|
Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
G Morris, E Athan, K Walder, CC Bortolasci, A O'Neil, W Marx, M Berk, AF Carvalho, M Maes, BK Puri |
Life Sciences | 2020 |
|
COVID-19 Drug Treatment in China
L Fan, S Jiang, X Yang, Z Wang, C Yang |
Current Pharmacology Reports | 2020 |
|
Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
HK Okur, K Yalcin, C Tastan, S Demir, B Yurtsever, GS Karakus, DD Kancagi, S Abanuz, U Seyis, R Zengin, C Hemsinlioglu, M Kara, ME Yildiz, E Deliceo, N Birgen, NB Pelit, C Cuhadaroglu, AS Kocagoz, E Ovali |
New Microbes and New Infections | 2020 |
|
Neurological consequences of COVID-19: what have we learned and where do we go from here?
A Jarrahi, M Ahluwalia, H Khodadadi, E da Silva Lopes Salles, R Kolhe, DC Hess, F Vale, M Kumar, B Baban, K Vaibhav, KM Dhandapani |
Journal of Neuroinflammation | 2020 |
|
Neutrophil Extracellular Traps: New Aspects
NV Vorobjeva |
Moscow University Biological Sciences Bulletin | 2020 |
|
COVID-19, Virology and Geroscience: A Perspective
C Vellas, P Delobel, PD Barreto, J Izopet |
The journal of nutrition, health & aging | 2020 |
|
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar |
International Immunopharmacology | 2020 |
|
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
J Hadjadj, N Yatim, L Barnabei, A Corneau, J Boussier, N Smith, H Péré, B Charbit, V Bondet, C Chenevier-Gobeaux, P Breillat, N Carlier, R Gauzit, C Morbieu, F Pène, N Marin, N Roche, TA Szwebel, SH Merkling, JM Treluyer, D Veyer, L Mouthon, C Blanc, PL Tharaux, F Rozenberg, A Fischer, D Duffy, F Rieux-Laucat, S Kernéis, B Terrier |
Science | 2020 |
|
Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy
AB Islam, AA Khan |
Scientific Reports | 2020 |
|
Psychiatric face of COVID-19
L Steardo, L Steardo, A Verkhratsky |
Translational Psychiatry | 2020 |
|
Nutrition, immunity and COVID-19
PC Calder |
2020 | |
|
COVID-19 as an Acute Inflammatory Disease
RH Manjili, M Zarei, M Habibi, MH Manjili |
Journal of immunology (Baltimore, Md. : 1950) | 2020 |
|
The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets
G Casucci, D Acanfora, RA Incalzi |
Drugs & Aging | 2020 |
|
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2
FL Poe, J Corn |
Medical Hypotheses | 2020 |
|
Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
ME Carter-Timofte, SE Jørgensen, MR Freytag, MM Thomsen, NS Andersen, A Al-Mousawi, AS Hait, TH Mogensen |
Frontiers in immunology | 2020 |
|
Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19
ML Belladonna, C Orabona |
Frontiers in pharmacology | 2020 |
|
Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?
A Kothari, V Singh, UK Nath, S Kumar, V Rai, K Kaushal, BJ Omar, A Pandey, N Jain |
Biology : open access journal | 2020 |
|
Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19
T Narasaraju, BM Tang, M Herrmann, S Muller, VT Chow, M Radic |
Frontiers in pharmacology | 2020 |
|
Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1
O Tarasova, S Ivanov, DA Filimonov, V Poroikov |
Molecules (Basel, Switzerland) | 2020 |
|
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
T Torres, L Puig |
American Journal of Clinical Dermatology | 2020 |
|
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Y Galipeau, M Greig, G Liu, M Driedger, MA Langlois |
Frontiers in immunology | 2020 |
|
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
RM Zellweger, TA Wartel, F Marks, M Song, JH Kim |
Expert Review of Vaccines | 2020 |
|
Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications
Y Ishay, A Kessler, A Schwarts, Y Ilan |
Hepatology Communications | 2020 |
|
Neutrophil extracellular traps and thrombosis in COVID-19
Y Zuo, M Zuo, S Yalavarthi, K Gockman, JA Madison, H Shi, W Woodard, SP Lezak, NL Lugogo, JS Knight, Y Kanthi |
Journal of Thrombosis and Thrombolysis | 2020 |
|
A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
JN Justice, S Gubbi, AS Kulkarni, JM Bartley, GA Kuchel, N Barzilai |
GeroScience | 2020 |
|
Diabetes, infection risk and COVID-19
S Erener |
Molecular Metabolism | 2020 |
|
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
S Lim, JH Bae, HS Kwon, MA Nauck |
Nature Reviews Endocrinology | 2020 |
|
Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
JC Smith, EL Sausville, V Girish, ML Yuan, A Vasudevan, KM John, JM Sheltzer |
Developmental Cell | 2020 |
|
Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19
R Jia, X Wang, P Liu, X Liang, Y Ge, H Tian, H Chang, H Zhou, M Zeng, J Xu |
Virologica Sinica | 2020 |
|
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
A Copaescu, O Smibert, A Gibson, EJ Phillips, JA Trubiano |
Journal of Allergy and Clinical Immunology | 2020 |
|
The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)
SK Das |
Indian Journal of Clinical Biochemistry | 2020 |
|
Natural Killer Cell Dysfunction and Its Role in COVID-19
C van Eeden, L Khan, MS Osman, JW Tervaert |
International journal of molecular sciences | 2020 |
|
SARS‐CoV2 and pregnancy: An invisible enemy?
S Verma, EB Carter, IU Mysorekar |
American Journal of Reproductive Immunology | 2020 |
|
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community
Hye Kyung Lee, Ludwig Knabl, Lisa Pipperger, Andre Volland, Priscilla Furth, Keunsoo Kang, Harold Smith, Ludwig Knabl, Romuald Bellmann, Christina Bernhard, Norbert Kaiser, Hannes Gänzer, Mathias Ströhle, Andreas Walser, Dorothee Von Laer, Lothar Hennighausen |
Research square | 2020 |
|
How SARS-CoV-2 (COVID-19) spreads within infected hosts — what we know so far
J Low, S Sanyal |
Emerging Topics in Life Sciences | 2020 |
|
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
L Perico, A Benigni, F Casiraghi, LF Ng, L Renia, G Remuzzi |
Nature Reviews Nephrology | 2020 |
|
COVID-19 and immunomodulation in IBD.
Neurath MF |
Gut | 2020 |
|
Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?
Giammaria D, Pajewski A |
Journal of Global Health | 2020 |
|
Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications.
Salvio G, Gianfelice C, Firmani F, Lunetti S, Balercia G, Giacchetti G |
Clinical Reviews in Bone and Mineral Metabolism | 2020 |
|
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.
Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H |
Molecular Psychiatry | 2020 |
|
Wildland firefighter exposure to smoke and COVID-19: A new risk on the fire line.
Navarro KM, Clark KA, Hardt DJ, Reid CE, Lahm PW, Domitrovich JW, Butler CR, Balmes JR |
The Science of The Total Environment | 2020 |
|
Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients.
Mutinelli-Szymanski P, Hude I, Merle E, Lombardi Y, Seris P, Abtahi M, Azeroual L, Bourgain C, Ensergueix G, Katerinis I, Kolko A, Kolta A, Maheas C, Mehrbanian S, Morel P, Ossman R, de Préneuf H, Roux A, Saltiel C, Vendé F, Verhoeven AS, Viron B, Laplanche S, Le Monnier A, Ridel C, Ureña-Torres P, Touzot M |
Clinical Kidney Journal | 2020 |
|
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G |
Journal of Clinical Medicine | 2020 |
|
Resistance of children to Covid-19. How?
Fischer A |
Mucosal Immunology | 2020 |
|
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
Radbel J, Narayanan N, Bhatt PJ |
Chest | 2020 |
|
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists.
Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, Huq S, Khalafallah AM, Koenecke A, Xiong R, Mensh B, Papadopoulos N, Kinzler KW, Vogelstein B, Vogelstein JT, Athey S, Zhou S, Bettegowda C |
Journal of Clinical Investigation | 2020 |
|
Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19.
Menendez JA |
Aging | 2020 |
|
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
Qu W, Wang Z, Hare JM, Bu G, Mallea JM, Pascual JM, Caplan AI, Kurtzberg J, Zubair AC, Kubrova E, Engelberg-Cook E, Nayfeh T, Shah VP, Hill JC, Wolf ME, Prokop LJ, Murad MH, Sanfilippo FP |
Stem Cells Translational Medicine | 2020 |
|
Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.
Russell SM, Alba-Patiño A, Barón E, Borges M, Gonzalez-Freire M, de la Rica R |
ACS Sensors | 2020 |
|
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Park SH, Choi JY, Kim SH, Jung I, Shin EC |
Science Immunology | 2020 |
|
Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19.
Chan AS, Rout A |
Journal of clinical medicine research | 2020 |
|
COVID-19: collaboration will keep us ahead of the curve.
Shamdasani P, Trubiano JA, Smibert OC, Owen CE, Liew DFL |
Internal Medicine Journal | 2020 |
|
Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review.
Ahmed MH, Hassan A |
2020 | |
|
The current understanding and potential therapeutic options to combat COVID-19.
Pooladanda V, Thatikonda S, Godugu C |
Life Sciences | 2020 |
|
Blood Targets of Adjuvant Drugs Against COVID19.
Di Micco P, Di Micco G, Russo V, Poggiano MR, Salzano C, Bosevski M, Imparato M, Fontanella L, Fontanella A |
Journal of blood medicine | 2020 |
|
COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives.
Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Majewski P, Rotter I, Kotfis K |
Brain Sciences | 2020 |
|
Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
O'Connell P, Aldhamen YA |
Human Vaccines & Immunotherapeutics | 2020 |
|
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
Arnaldez FI, O'Day SJ, Drake CG, Fox BA, Fu B, Urba WJ, Montesarchio V, Weber JS, Wei H, Wigginton JM, Ascierto PA |
Journal for ImmunoTherapy of Cancer | 2020 |
|
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
Encinar JA, Menendez JA |
Viruses | 2020 |
|
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.
Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, Xie J, Guan W, Liang W, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Zheng J, Zhang N, Li Y, He J, Li J, Li S, Zhong N |
Journal of Allergy and Clinical Immunology | 2020 |
|
Headaches During COVID-19: My Clinical Case and Review of the Literature.
Belvis R |
Headache: The Journal of Head and Face Pain | 2020 |
|
Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
Pahan P, Pahan K |
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2020 |
|
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L |
Cytokine & Growth Factor Reviews | 2020 |
|
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.
Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA |
Journal of Clinical Medicine | 2020 |
|
Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?
Abdullah A, Neurath MF, Atreya R |
Viszeralmedizin | 2020 |
|
Comparative ACE2 variation and primate COVID-19 risk.
Melin AD, Janiak MC, Marrone F 3rd, Arora PS, Higham JP |
2020 | |
|
Immune Correlates of COVID-19 Control.
Poonia B, Kottilil S |
Frontiers in immunology | 2020 |
|
Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.
Zhang Y, Chen Y, Meng Z |
Frontiers in immunology | 2020 |
|
Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?
Laganà AS, Unfer V, Garzon S, Bizzarri M |
Medical Hypotheses | 2020 |
|
Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2
Masih A, Agnihotri AK, Srivastava JK, Pandey N, Bhat HR, Singh UP |
Journal of Biochemical and Molecular Toxicology | 2020 |
|
Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.
Smetana K Jr, Brábek J |
In vivo (Athens, Greece) | 2020 |
|
Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin.
Aljaberi R, Wishah K |
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2020 |
|
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
Solerte SB, Di Sabatino A, Galli M, Fiorina P |
Acta Diabetologica | 2020 |
|
Hepatic consequences of COVID-19 infection. Lapping or biting?
Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A |
European Journal of Internal Medicine | 2020 |
|
Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Drak Alsibai K |
Medical Hypotheses | 2020 |
|
Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.
Bautista-Vargas M, Bonilla-Abadía F, Cañas CA |
Journal of Thrombosis and Thrombolysis | 2020 |
|
Hypothesis to explain the severe form of COVID-19 in Northern Italy.
Cegolon L, Pichierri J, Mastrangelo G, Cinquetti S, Sotgiu G, Bellizzi S, Pichierri G |
BMJ global health | 2020 |
|
IL-15 immunotherapy is a viable strategy for COVID-19.
Kandikattu HK, Venkateshaiah SU, Kumar S, Mishra A |
Cytokine & Growth Factor Reviews | 2020 |
|
Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19.
McCord JM, Hybertson BM, Cota-Gomez A, Geraci KP, Gao B |
2020 | |
|
Why such excess of mortality for COVID-19 in Spain?
Soriano V, Barreiro P |
Therapeutic advances in infectious disease | 2020 |
|
A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.
Yu WL, Toh HS, Liao CT, Chang WT |
Cardiovascular Drugs and Therapy | 2020 |
|
Possible role of vitamin D in Covid-19 infection in pediatric population.
Panfili FM, Roversi M, D'Argenio P, Rossi P, Cappa M, Fintini D |
Journal of Endocrinological Investigation | 2020 |
|
Pharmacokinetics of a single inhalation of hydrogen gas in pigs.
Sano M, Ichihara G, Katsumata Y, Hiraide T, Hirai A, Momoi M, Tamura T, Ohata S, Kobayashi E |
PloS one | 2020 |
|
COVID-19 revisiting inflammatory pathways of arthritis.
Schett G, Manger B, Simon D, Caporali R |
Nature reviews. Rheumatology | 2020 |
|
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.
Moll G, Drzeniek N, Kamhieh-Milz J, Geissler S, Volk HD, Reinke P |
Frontiers in immunology | 2020 |
|
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19.
Chang, Zhao P, Zhang D, Dong JH, Xu Z, Yang G, Li BY, Liu HX, Li BA, Qin CF, Peng XH, Wang FS, Xie LX, Chen Z, Dela Cruz CS, Sharma L, Qin EQ |
The journal of allergy and clinical immunology. In practice | 2020 |
|
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
Wu L, O'Kane AM, Peng H, Bi Y, Motriuk-Smith D, Ren J |
Biochemical Pharmacology | 2020 |
|
Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection.
He LH, Ren LF, Li JF, Wu YN, Li X, Zhang L |
Frontiers in microbiology | 2020 |
|
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Tsuchiya A, Takeuchi S, Iwasawa T, Kumagai M, Sato T, Motegi S, Ishii Y, Koseki Y, Tomiyoshi K, Natsui K, Takeda N, Yoshida Y, Yamazaki F, Kojima Y, Watanabe Y, Kimura N, Tominaga K, Kamimura H, Takamura M, Terai S |
Ensho Saisei | 2020 |
|
The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection.
Shen Q, Xiao X, Aierken A, Yue W, Wu X, Liao M, Hua J |
Journal of Cellular and Molecular Medicine | 2020 |
|
COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports.
Prasad A, Panhwar S, Hendel RC, Sheikh O, Mushtaq Z, Dollar F, Vinas A, Alraies C, Almonani A, Nguyen TH, Amione-Guerra J, Foster MT, Sisson C, Anderson A, George JC, Kutkut I, Guareña Casillas JA, Badin A |
American Heart Journal | 2020 |
|
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.
Malik YS, Kumar N, Sircar S, Kaushik R, Bhat S, Dhama K, Gupta P, Goyal K, Singh MP, Ghoshal U, El Zowalaty ME, O R V, Yatoo MI, Tiwari R, Pathak M, Patel SK, Sah R, Rodriguez-Morales AJ, Ganesh B, Kumar P, Singh RK |
2020 | |
|
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19.
García LF |
Frontiers in immunology | 2020 |
|
COVID-19: Discovery, diagnostics and drug development.
Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF |
Journal of Hepatology | 2020 |
|
Silent hypoxia: higher NO in red blood cells of COVID-19 patients.
Mortaz E, Malkmohammad M, Jamaati H, Naghan PA, Hashemian SM, Tabarsi P, Varahram M, Zaheri H, Chousein EGU, Folkerts G, Adcock IM |
BMC Pulmonary Medicine | 2020 |
|
COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management.
Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, Chen Z, Wang Z |
Frontiers in neurology | 2020 |
|
Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
Guo H, Sheng Y, Li W, Li F, Xie Z, Li J, Zhu Y, Geng J, Liu G, Wang L, Li J, Wang F |
Frontiers in Medicine | 2020 |
|
Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction.
Roberts KA, Colley L, Agbaedeng TA, Ellison-Hughes GM, Ross MD |
Frontiers in Cardiovascular Medicine | 2020 |
|
Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020.
Kaeuffer C, Le Hyaric C, Fabacher T, Mootien J, Dervieux B, Ruch Y, Hugerot A, Zhu YJ, Pointurier V, Clere-Jehl R, Greigert V, Kassegne L, Lefebvre N, Gallais F, Meyer N, Hansmann Y, Hinschberger O, Danion F |
Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin | 2020 |
|
Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients.
Martinez-Urbistondo M, Mora-Vargas A, Expósito-Palomo E, Castejón R, Citores MJ, Rosado S, de Mendoza C, Baños I, Fernández-Cruz A, Daimiel L, San-Cristóbal R, Vargas JA, Martinez JA |
Mediators of Inflammation | 2020 |
|
COVID-19-Associated Acute Kidney Injury and Quantified Protein Catabolic Rate: A Likely Effect of Cytokine Storm on Muscle Protein Breakdown.
Uribarri J, El Shamy O, Sharma S, Winston J |
2020 | |
|
A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2.
Kivrak A, Ulaş B, Kivrak H |
International Immunopharmacology | 2020 |
|
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.
Bacca E, Digaetano M, Meschiari M, Franceschini E, Menozzi M, Cuomo G, Mussini C |
Biochemical and Biophysical Research Communications | 2020 |
|
In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease.
Epelbaum O, Galperin I |
2020 | |
|
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform.
Russo G, Pennisi M, Fichera E, Motta S, Raciti G, Viceconti M, Pappalardo F |
BMC bioinformatics | 2020 |
|
HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper.
Fidler S, Lewin S, Deeks S, Sogaard OS, Vanderkerckhove L, Collins S, Kelly D, Singh J, Caskey M, Frater J |
Journal of virus eradication | 2020 |
|
Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
Giovinazzo G, Gerardi C, Uberti-Foppa C, Lopalco L |
Molecules (Basel, Switzerland) | 2020 |
|
Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation.
Yang C, Keshavjee S, Liu M |
Frontiers in pharmacology | 2020 |
|
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications.
Yu S, Yu M |
Frontiers in Cell and Developmental Biology | 2020 |
|
Cell-mediated immunity to SARS-CoV-2.
Wang X, Gui J |
2020 | |
|
Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.
Mello MT, Silva A, Guerreiro RC, da-Silva FR, Esteves AM, Poyares D, Piovezan R, Treptow E, Starling M, Rosa DS, Pires GN, Andersen ML, Tufik S |
2020 | |
|
Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression.
Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS |
Diabetes & metabolic syndrome | 2020 |
|
Wide spectrum of clinical picture of COVID-19 in children - From mild to severe disease.
Mania A, Mazur-Melewska K, Lubarski K, Kuczma-Napierała J, Mazurek J, Jończyk-Potoczna K, Służewski W, Figlerowicz M |
Journal of Infection and Public Health | 2020 |
|
Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
Lim HX, Lim J, Jazayeri SD, Poppema S, Poh CL |
Biomedical journal | 2020 |
|
The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients.
Du H, Wang DW, Chen C |
Journal of Cellular and Molecular Medicine | 2020 |
|
Is there an association between oral health and severity of COVID-19 complications?
Botros N, Iyer P, Ojcius DM |
Biomedical journal | 2020 |
|
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, Pugliese D, Neri M, Cammarota G, Ringel Y, Costamagna G, Gasbarrini A, Boskoski I, Armuzzi A |
Inflammatory Bowel Diseases | 2020 |
|
Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study.
de la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, Rialp G, Socias L, Masmiquel L, Gonzalez-Freire M |
Microorganisms | 2020 |
|
Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.
Rao KS, Suryaprakash V, Senthilkumar R, Preethy S, Katoh S, Ikewaki N, Abraham SJK |
Frontiers in immunology | 2020 |
|
Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients.
Schiaffino MT, Di Natale M, García-Martínez E, Navarro J, Muñoz-Blanco JL, Demelo-Rodríguez P, Sánchez-Mateos P |
The Journal of Infectious Diseases | 2020 |
|
The potential role of the carotid body in COVID-19.
Porzionato A, Emmi A, Stocco E, Barbon S, Boscolo-Berto R, Macchi V, De Caro R |
American journal of physiology. Lung cellular and molecular physiology | 2020 |
|
COVID-19: The Immune Responses and Clinical Therapy Candidates.
Zhand S, Saghaeian Jazi M, Mohammadi S, Tarighati Rasekhi R, Rostamian G, Kalani MR, Rostamian A, George J, Douglas MW |
International journal of molecular sciences | 2020 |
|
The eye: "An organ that must not be forgotten in coronavirus disease 2019 (COVID-2019) pandemic".
Durán C SC, Mayorga G DC |
Journal of Optometry | 2020 |
|
Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.
Li T, Guo Y, Zhuang X, Huang L, Zhang X, Wei F, Yang B |
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association | 2020 |
|
A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic-related cytokine release syndrome.
Ye C, Yang H, Cheng M, Shultz LD, Greiner DL, Brehm MA, Keck JG |
The FASEB Journal | 2020 |
|
COVID-19: An Update Regarding the Quest for Finding an Effective Cure.
Bangash FS, Saeed G, Shahab P, Waheed A |
Cureus | 2020 |
|
Sympathetic activation: a potential link between comorbidities and COVID-19.
Porzionato A, Emmi A, Barbon S, Boscolo-Berto R, Stecco C, Stocco E, Macchi V, De Caro R |
The FEBS journal | 2020 |
|
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
Zheng C, Kar I, Chen CK, Sau C, Woodson S, Serra A, Abboud H |
CNS Drugs | 2020 |
|
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.
Montesarchio V, Parrela R, Iommelli C, Bianco A, Manzillo E, Fraganza F, Palumbo C, Rea G, Murino P, De Rosa R, Atripaldi L, D'Abbraccio M, Curvietto M, Mallardo D, Celentano E, Grimaldi AM, Palla M, Trojaniello C, Vitale MG, Million-Weaver SL, Ascierto PA |
Journal for ImmunoTherapy of Cancer | 2020 |
|
Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
Benani A, Ben Mkaddem S |
Frontiers in immunology | 2020 |
|
Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.
Kahn R, Schmidt T, Golestani K, Mossberg A, Gullstrand B, Bengtsson AA, Kahn F |
Journal of leukocyte biology | 2020 |
|
The role of Interleukin 6 inhibitors in therapy of severe COVID-19.
Nasonov E, Samsonov M |
Biomedicine & Pharmacotherapy | 2020 |
|
Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.
Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El Haj R, Mahir W, Belayachi L, Belefquih B, Benouda A, Cheikh A, Langlois MA, Cherrah Y, Flamand L, Guessous F, Boilard E |
Circulation research | 2020 |
|
Candesartan could ameliorate the COVID-19 cytokine storm.
Elkahloun AG, Saavedra JM |
Biomedicine & Pharmacotherapy | 2020 |
|
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, Polacco BJ, Melnyk JE, Ulferts S, Kaake RM, Batra J, Richards AL, Stevenson E, Gordon DE, Rojc A, Obernier K, Fabius JM, Soucheray M, Miorin L, Moreno E, Koh C, Tran QD, Hardy A, Robinot R, Vallet T, Nilsson-Payant BE, Hernandez-Armenta C, Dunham A, Weigang S, Knerr J, Modak M, Quintero D, Zhou Y, Dugourd A, Valdeolivas A, Patil T, Li Q, Hüttenhain R, Cakir M, Muralidharan M, Kim M, Jang G, Tutuncuoglu B, Hiatt J, Guo JZ, Xu J, Bouhaddou S, Mathy CJ, Gaulton A, Manners EJ, Félix E, Shi Y, Goff M, Lim JK, McBride T, O\u2019Neal MC, Cai Y, Chang JC, Broadhurst DJ, Klippsten S, De wit E, Leach AR, Kortemme T, Shoichet B, Ott M, Saez-Rodriguez J, tenOever BR, Mullins RD, Fischer ER, Kochs G, Grosse R, García-Sastre A, Vignuzzi M, Johnson JR, Shokat KM, Swaney DL, Beltrao P, Krogan NJ |
Cell | 2020 |
|
Dissemination of the bla NDM-5 Gene via IncX3-Type Plasmid among Enterobacteriaceae in Children.
Tian D, Wang B, Zhang H, Pan F, Wang C, Shi Y, Sun Y |
mSphere | 2020 |
|
Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks.
Tatara AM |
Tissue Engineering Part A | 2020 |
|
COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
Schett G, Sticherling M, Neurath MF |
Nature reviews. Immunology | 2020 |
|
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
Elens L, Langman LJ, Hesselink DA, Bergan S, Moes DJAR, Molinaro M, Venkataramanan R, Lemaitre F |
Therapeutic Drug Monitoring | 2020 |
|
The intriguing features of COVID-19 in children and its impact on the pandemic.
Safadi MAP |
Jornal de Pediatria | 2020 |
|
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R |
Journal of Autoimmunity | 2020 |
|
A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.
Sriram K, Insel PA |
British Journal of Pharmacology | 2020 |
|
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2.
Ebrahimi SA |
Drug Development Research | 2020 |
|
Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections.
Calder PC, Carr AC, Gombart AF, Eggersdorfer M |
Nutrients | 2020 |
|
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
Kai H, Kai M |
Hypertension research : official journal of the Japanese Society of Hypertension | 2020 |
|
Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China.
Liu Y, Chang C, Lu Q |
European Journal of Rheumatology | 2020 |
|
Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?
Osman MS, van Eeden C, Cohen Tervaert JW |
Autoimmunity Reviews | 2020 |
|
The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets.
Babadaei MMN, Hasan A, Bloukh SH, Edis Z, Sharifi M, Kachooei E, Falahati M |
Journal of Biomolecular Structure and Dynamics | 2020 |
|
Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.
Zheng Y, Li R, Liu S |
Journal of Medical Virology | 2020 |
|
Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective.
Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, Mansour S, Zhao X, Ybarra LF, Abbate A, Vilca LM, Azzalini L |
The Canadian journal of cardiology | 2020 |
|
Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.
Tilocca B, Soggiu A, Sanguinetti M, Babini G, De Maio F, Britti D, Zecconi A, Bonizzi L, Urbani A, Roncada P |
Microbes and Infection | 2020 |
|
Can Zn Be a Critical Element in COVID-19 Treatment?
Rahman MT, Idid SZ |
Biological Trace Element Research | 2020 |
|
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
Richez C, Flipo RM, Berenbaum F, Cantagrel A, Claudepierre P, Debiais F, Dieudé P, Goupille P, Roux C, Schaeverbeke T, Wendling D, Pham T, Thomas T |
Joint, bone, spine : revue du rhumatisme | 2020 |
|
SARS-CoV-2 Infection and the Liver.
Morgan K, Samuel K, Vandeputte M, Hayes PC, Plevris JN |
2020 | |
|
A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2.
Baek WK, Sohn SY, Mahgoub A, Hage R |
Cureus | 2020 |
|
COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT.
Olivari L, Riccardi N, Rodari P, Angheben A, Artioli P, Salgarello M |
European Journal of Nuclear Medicine and Molecular Imaging | 2020 |
|
A case of cytokine hemofiltration and extracorporeal life support as treatment of coronavirus disease 2019 (COVID-19) respiratory failure.
Al-Qudsi O, Whitson B, Bhatt A, Chucta S, Tripathi R |
The Journal of Thoracic and Cardiovascular Surgery | 2020 |
|
Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.
Tang H, Tian JB, Dong JW, Tang XT, Yan ZY, Zhao YY, Xiong F, Sun X, Song CX, Xiang CG, Tu C, Lei CT, Liu J, Su H, Huang J, Qiu Y, Miao XP, Zhang C |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2020 |
|
Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide.
Baba H, Kanamori H, Oshima K, Seike I, Niitsuma-Sugaya I, Takei K, Sato Y, Tokuda K, Aoyagi T |
Journal of Infection and Chemotherapy | 2020 |
|
Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review.
Sohag AAM, Hannan MA, Rahman S, Hossain M, Hasan M, Khan MK, Khatun A, Dash R, Uddin MJ |
Drug Development Research | 2020 |
|
Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y, Mao L, Yuan X, Xue Y, Lin Q, Tang G, Song H, Wang F, Sun Z |
Journal of Clinical Immunology | 2020 |
|
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.
Haslak F, Yildiz M, Adrovic A, Sahin S, Koker O, Aliyeva A, Barut K, Kasapcopur O |
Rheumatology International | 2020 |
|
Addressing male sexual and reproductive health in the wake of COVID-19 outbreak.
Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Vena W, Jannini EA |
Journal of Endocrinological Investigation | 2020 |
|
A Perspective on Yoga as a Preventive Strategy for Coronavirus Disease 2019.
Nagarathna R, Nagendra HR, Majumdar V |
International journal of yoga | 2020 |
|
The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
Villena J, Kitazawa H |
Frontiers in physiology | 2020 |
|
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
Naz F, Arish M |
Frontiers in immunology | 2020 |
|
What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?
Al-Harthi L, Campbell E, Schneider JA, Bennett DA |
AIDS Research and Human Retroviruses | 2020 |
|
Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
Dragonetti D, Guarini G, Pizzuti M |
Blood transfusion = Trasfusione del sangue | 2020 |
|
Geographic components of SARS-CoV-2 expansion: a hypothesis.
Joyce KE, Weaver SR, Lucas SJE |
Journal of applied physiology | 2020 |
|
Current Landscape of Imaging and the Potential Role for Artificial Intelligence in the Management of COVID-19.
Shaikh F, Andersen MB, Sohail MR, Mulero F, Awan O, Dupont-Roettger D, Kubassova O, Dehmeshki J, Bisdas S |
Current Problems in Diagnostic Radiology | 2020 |
|
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.
Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss MM, Heppt F, Meder C, Atreya R, Klenske E, Dietrich P, Abdullah A, Kliem T, Corte G, Morf H, Leppkes M, Kremer AE, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Maier C, Hueber AJ, Manger K, Manger B, Berking C, Tenbusch M, Überla K, Sticherling M, Neurath MF, Schett G |
Nature Communications | 2020 |
|
Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults.
Hornick A, Tashtish N, Osnard M, Shah B, Bradigan A, Albar Z, Tomalka J, Dalton J, Sharma A, Sekaly RP, Hejal R, Simon DI, Zidar DA, Al-Kindi SG |
Pathogens & immunity | 2020 |
|
Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
Zhong Y, Cao Y, Zhong X, Peng Z, Jiang S, Tang T, Chen H, Li X, Xia Y, Cheng Y, Zhao X |
American Journal of Obstetrics and Gynecology | 2020 |
|
Tea Bioactive Modulate Innate Immunity: In Perception to COVID-19 Pandemic.
Chowdhury P, Barooah AK |
Frontiers in immunology | 2020 |
|
Potential Use of Alpha-1 Anti-trypsin in the Covid-19 Treatment.
Martini F, De Mattei M, Contini C, Tognon MG |
Frontiers in Cell and Developmental Biology | 2020 |
|
Clinical Impact Potential of Supplemental Nutrients as Adjuncts of Therapy in High-Risk COVID-19 for Obese Patients.
Sahin E, Orhan C, Uckun FM, Sahin K |
Frontiers in Nutrition | 2020 |
|
Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes.
Kelleni MT |
Biomedicine & Pharmacotherapy | 2020 |
|
Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
Kim WR, Park EG, Kang KW, Lee SM, Kim B, Kim HS |
Molecules and Cells | 2020 |
|
Herd immunity against COVID-19: is it enough to stop a second wave?
AbdAllah M, Cordie A |
New Microbes and New Infections | 2020 |
|
Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
Sriram K, Loomba R, Insel PA |
Proceedings of the National Academy of Sciences | 2020 |
|
Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN, Elrashdy F, Aljadawi A, Ali SM, Khan RH, Redwan EM |
Journal of Neuroscience Research | 2020 |
|
How can clinical immunology laboratories contribute to the management of severe COVID-19 cases in limited resource contexts?
Admou B, Hachimi A, Samkaoui MA |
African Journal of Laboratory Medicine | 2020 |
|
Antivirals With Adjunctive Corticosteroids Prevent Clinical Progression of Early Coronavirus 2019 Pneumonia: A Retrospective Cohort Study.
Ooi ST, Parthasarathy P, Lin Y, Nallakaruppan VD, Ng S, Tan TC, Low S, Tang T |
Open Forum Infectious Diseases | 2020 |
|
Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on high-risk groups and preventative healthcare.
McAuliffe S, Ray S, Fallon E, Bradfield J, Eden T, Kohlmeier M |
2020 | |
|
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
Nagarkatti P, Miranda K, Nagarkatti M |
Frontiers in pharmacology | 2020 |
|
N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.
Nunes-Santos CJ, Kuehn HS, Rosenzweig SD |
Journal of Clinical Immunology | 2020 |
|
COVID-19 mortality risk factors in older people in a long-term care center.
Heras E, Garibaldi P, Boix M, Valero O, Castillo J, Curbelo Y, Gonzalez E, Mendoza O, Anglada M, Miralles JC, Llull P, Llovera R, Piqué JM |
European Geriatric Medicine | 2020 |
|
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
Nagy B Jr, Fejes Z, Szentkereszty Z, Sütő R, Várkonyi I, Ajzner É, Kappelmayer J, Papp Z, Tóth A, Fagyas M |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
|
Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced "cytokines storm".
Giuliani C, Bucci I, Napolitano G |
Medical Hypotheses | 2020 |
|
COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations.
Jacob G, Aharon A, Brenner B |
Frontiers in physiology | 2020 |
|
SARS-CoV-2 infection and psychiatric manifestations in a previous healthy patient.
Lorenzo-Villalba N, Jannot X, Syrovatkova A, Michel V, Andrès E |
Caspian Journal of Internal Medicine | 2020 |
|
Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19.
Bellmann-Weiler R, Lanser L, Burkert F, Seiwald S, Fritsche G, Wildner S, Schroll A, Koppelstätter S, Kurz K, Griesmacher A, Weiss G |
Open Forum Infectious Diseases | 2020 |
|
Real-time measurement of the uncertain epidemiological appearances of COVID-19 infections.
Gupta M, Jain R, Taneja S, Chaudhary G, Khari M, Verdú E |
Applied Soft Computing | 2020 |
|
Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses.
Shawky E, Nada AA, Ibrahim RS |
RSC Advances | 2020 |
|
Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
Lorenz G, Moog P, Bachmann Q, La Rosée P, Schneider H, Schlegl M, Spinner C, Heemann U, Schmid RM, Algül H, Lahmer T, Huber W, Schmaderer C |
Scientific Reports | 2020 |
|
Gordian Knot: Gastrointestinal lesions caused by three highly pathogenic coronaviruses from SARS-CoV and MERS-CoV to SARS-CoV-2.
Meng X, Lou QY, Yang WY, Chen R, Xu WH, Yang Y, Zhang L, Xu T, Xiang HF |
European Journal of Pharmacology | 2020 |
|
Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019.
DeGrado JR, Szumita PM, Schuler BR, Dube KM, Lenox J, Kim EY, Weinhouse GL, Massaro AF |
2020 | |
|
Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections on Testis.
Achua JK, Chu KY, Ibrahim E, Khodamoradi K, Delma KS, Iakymenko OA, Kryvenko ON, Arora H, Ramasamy R |
The World Journal of Men's Health | 2020 |
|
Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
Delorme-Axford E, Klionsky DJ |
Autophagy | 2020 |
|
Predictive Nomogram for Severe COVID-19 and Identification of Mortality-Related Immune Features.
Cai L, Zhou X, Wang M, Mei H, Ai L, Mu S, Zhao X, Chen W, Hu Y, Wang H |
The journal of allergy and clinical immunology. In practice | 2020 |
|
Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series.
Mady A, Aletreby W, Abdulrahman B, Lhmdi M, Noor AM, Alqahtani SA, Soliman I, Alharthy A, Karakitsos D, Memish ZA |
2020 | |
|
The intriguing features of COVID‐19 in children and its impact on the pandemic
Safadi MA |
Jornal de Pediatria (Versão em Português) | 2020 |
|
Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not
Balasubramanian S, Rao NM, Goenka A, Roderick M, Ramanan AV |
Indian Pediatrics | 2020 |
|
Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS‐CoV‐2 (COVID‐19) pandemic emergency: A quick review for a quick consultation
Paolino G, Mercuri SR, Bearzi P, Mattozzi C |
Dermatologic Therapy | 2020 |
|
COVID‐19, internists and resilience: the north‐south Italy outbreak
Di Ciaula A, Palmieri VO, Migliore G, Portincasa P |
European Journal of Clinical Investigation | 2020 |
|
Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)
Baig AM, Sanders EC |
Journal of Medical Virology | 2020 |
|
COVID‐19: A Global Threat to the Nervous System
Koralnik IJ, Tyler KL |
Annals of Neurology | 2020 |
|
Can steroids reverse the severe COVID‐19 induced “cytokine storm”?
Kolilekas L, Loverdos K, Giannakaki S, Vlassi L, Levounets A, Zervas E, Gaga M |
Journal of Medical Virology | 2020 |
|
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, Franceschini E, Cuomo G, Orlando G, Borghi V, Santoro A, Di Gaetano M, Puzzolante C, Carli F, Bedini A, Corradi L, Fantini R, Castaniere I, Tabbì L, Girardis M, Tedeschi S, Giannella M, Bartoletti M, Pascale R, Dolci G, Brugioni L, Pietrangelo A, Cossarizza A, Pea F, Clini E, Salvarani C, Massari M, Viale PL, Mussini C |
2020 | |
|
COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics
Portincasa P, Krawczyk M, Smyk W, Lammert F, Di Ciaula A |
European Journal of Clinical Investigation | 2020 |
|
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment
Raza SS, Khan MA |
Cytotherapy | 2020 |
|
COVID-19–Associated Acute Kidney Injury: A Case Series
Patel N, Rein JL, Sanchez-Russo L, Winston J, Uribarri J |
2020 | |
|
COVID-19 Infection Presenting as Acute-Onset Focal Status Epilepticus
Swarz JA, Daily S, Niemi E, Hilbert SG, Ibrahim HA, Gaitanis JN |
Pediatric Neurology | 2020 |
|
Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with SARS‐CoV‐2
Yang Y, Ding L, Zou X, Shen Y, Hu D, Hu X, Li Z, Kamel IR |
Obesity (Silver Spring, Md.) | 2020 |
|
Systemic inflammation as fuel for acute liver injury in COVID-19
Effenberger M, Grander C, Grabherr F, Griesmacher A, Ploner T, Hartig F, Bellmann-Weiler R, Joannidis M, Zoller H, Weiss G, Adolph TE, Tilg H |
Digestive and Liver Disease | 2020 |
|
COVID-19 related deaths in an urban academic medical center in Brooklyn – a descriptive case series
McCracken JA, Nakeshbandi M, Arace J, Riley WJ, Sharma R |
Translational Medicine Communications | 2020 |
|
Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS
Perlin DS, Zafir-Lavie I, Roadcap L, Raines S, Ware CF, Neil GA |
mSphere | 2020 |
|
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Bhuiyan FR, Howlader S, Raihan T, Hasan M |
Frontiers in Medicine | 2020 |
|
Cardiovascular Diseases (CVDs) in COVID-19 Pandemic Era
Gerc V, Masic I, Salihefendic N, Zildzic M |
Materia socio-medica | 2020 |
|
Elovanoid-N32 or RvD6-isomer decrease ACE2 and binding of S protein RBD after injury or INFγ in the eye
Pham TL, He J, Kakazu AH, Calandria J, Do KV, Nshimiyimana R, Petasis NA, Bazan HE, Bazan NG |
Research square | 2020 |
|
Putative Natural History of CoViD-19
Chiappell F |
Bioinformation | 2020 |
|
The relationship between human coronaviruses, asthma and allergy—An unresolved dilemma
Chałubiński M, Gajewski A, Kowalski ML |
Clinical & Experimental Allergy | 2020 |
|
Lifting the mask on neurological manifestations of COVID-19
Pezzini A, Padovani A |
Nature reviews. Neurology | 2020 |
|
Be aware of acute kidney injury in critically ill children with COVID-19
Wang X, Chen X, Tang F, Luo W, Fang J, Qi C, Sun H, Xiao H, Peng X, Shao J |
Pediatric nephrology (Berlin, Germany) | 2020 |
|
Mental illnesses among COVID-19 patients: Possible immunological underpinnings
Kar SK, Verma P, Verma SK, Saxena SK |
Asian Journal of Psychiatry | 2020 |
|
Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients
Rai SN, Qian C, Pan J, Seth A, Srivastava DK, Bhatnagar A |
BMC medical research methodology | 2020 |
|
Beta‐Adrenergic Blockers as a Potential Treatment for COVID‐19 Patients
Vasanthakumar N |
BioEssays | 2020 |
|
Potential Applications of Nanomaterials to Quench the Cytokine Storm in Coronavirus Disease 19
Pisani A, Pompa PP, Bardi G |
Frontiers in Bioengineering and Biotechnology | 2020 |
|
Tocilizumab for severe COVID-19 related illness – A community academic medical center experience
Meleveedu KS, Miskovsky J, Meharg J, Abdelrahman A, Tandon R, Moody AE, Dasilva P, Masse G, LaPorte J, Saied Calvino A, Allen G, El-Bizri R, Roberts T, Armenio V, Katz SC |
Cytokine | 2020 |
|
The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunction
Rowaiye AB, Onuh OA, Oli AN, Okpalefe OA, Oni S, Nwankwo EJ |
The Pan African medical journal | 2020 |
|
Opportunistic physiology: inserting physiology and pathophysiology content into virtually delivered clinical rotations
Wilson TE, Mulye M, Akbar S |
AJP Advances in Physiology Education | 2020 |
|
Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW
Zheng S, Baak JP, Li S, Xiao W, Ren H, Yang H, Gan Y, Wen C |
Phytomedicine | 2020 |
|
Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
Caracciolo M, Macheda S, Labate D, Tescione M, La Scala S, Vadalà E, Squillaci R, D\u2019Aleo F, Morabito A, Garreffa C, Marciano MC, Oliva EN |
Frontiers in immunology | 2020 |
|
The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease
d\u2019Arminio Monforte A, Tavelli A, Bai F, Tomasoni D, Falcinella C, Castoldi R, Barbanotti D, Mulè G, Allegrini M, Tesoro D, Tagliaferri G, Mondatore D, Augello M, Cona A, Ancona G, Gazzola L, Iannotti N, Tincati C, Viganò O, De Bona A, Bini T, Cozzi-Lepri A, Marchetti G |
International Journal of Infectious Diseases | 2020 |
|
Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses
Borges do Nascimento IJ, von Groote TC, O\u2019Mathúna DP, Abdulazeem HM, Henderson C, Jayarajah U, Weerasekara I, Poklepovic Pericic T, Klapproth HE, Puljak L, Cacic N, Zakarija-Grkovic I, Guimarães SM, Atallah AN, Bragazzi NL, Marcolino MS, Marusic A, Jeroncic A |
PloS one | 2020 |
|
Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy
Hong R, Zhao H, Wang Y, Chen Y, Cai H, Hu Y, Wei G, Huang H |
Bone Marrow Transplantation | 2020 |
|
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Ansarin K, Tolouian R, Ardalan M, Taghizadieh A, Varshochi M, Teimouri S, Vaezi T, Valizadeh H, Saleh P, Safiri S, Chapman KR |
BioImpacts : BI | 2020 |
|
2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
Simões e Silva AC, Lanza K, Palmeira VA, Costa LB, Flynn JT |
Pediatric nephrology (Berlin, Germany) | 2020 |
|
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
Costa LB, Perez LG, Palmeira VA, Macedo e Cordeiro T, Ribeiro VT, Lanza K, Simões e Silva AC |
Frontiers in Cell and Developmental Biology | 2020 |
|
Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
Fang J, Li H, Du W, Yu P, Guan YY, Ma SY, Liu D, Chen W, Shi GC, Bian XL |
Frontiers in pharmacology | 2020 |
|
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara A, Mitrev Z, Rosalia RA, Assas BM |
Open Biology | 2020 |
|
Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID‐19): Are they similar?
Paltrinieri S, Giordano A, Stranieri A, Lauzi S |
Transboundary and Emerging Diseases | 2020 |
|
Coronavirus: A possible cause of reduced male fertility
Huang C, Ji X, Zhou W, Huang Z, Peng X, Fan L, Lin G, Zhu W |
Andrologia | 2020 |
|
Increased Metabolic Burden Among Blacks: A Putative Mechanism for Disparate COVID-19 Outcomes
Jean-Louis G, Turner AD, Jin P, Liu M, Boutin-Foster C, McFarlane SI, Seixas A |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2020 |
|
Occurrence of pulmonary embolism related to COVID-19
Hauguel-Moreau M, Hajjam ME, De Baynast Q, Vieillard-Baron A, Lot AS, Chinet T, Mustafic H, Bégué C, Carlier RY, Geri G, Dubourg O, Beaune S, Mansencal N |
Journal of Thrombosis and Thrombolysis | 2020 |
|
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
Formiga FR, Leblanc R, de Souza Rebouças J, Farias LP, de Oliveira RN, Pena L |
Journal of Controlled Release | 2020 |
|
An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
Agrawal H, Das N, Nathani S, Saha S, Saini S, Kakar SS, Roy P |
Stem Cell Reviews and Reports | 2020 |
|
COVID-19: benefits and risks of passive immunotherapeutics
Gupta A, Karki R, Dandu HR, Dhama K, Bhatt ML, Saxena SK |
Human Vaccines & Immunotherapeutics | 2020 |
|
A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency
Daou S, Talukdar M, Tang J, Dong B, Banerjee S, Li Y, Duffy NM, Ogunjimi AA, Gaughan C, Jha BK, Gish G, Tavernier N, Mao D, Weiss SR, Huang H, Silverman RH, Sicheri F |
Proceedings of the National Academy of Sciences | 2020 |
|
Role of micronutrients in the management of coronavirus disease 2019
AbdAllah M, Ez Elarab H, Raslan E, Saber L, Daoud E, Saber M |
New Microbes and New Infections | 2020 |
|
Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
Chen X, Wu Y, Chen C, Gu Y, Zhu C, Wang S, Chen J, Zhang L, Lv L, Zhang G, Yuan Y, Chai Y, Zhu M, Wu C |
Acta pharmaceutica Sinica. B | 2020 |
|
Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions
Awortwe C, Cascorbi I |
Pharmacological Research | 2020 |
|
The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals
Cañas CA |
Medical Hypotheses | 2020 |
|
A materials-science perspective on tackling COVID-19
Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W |
Nature Reviews Materials | 2020 |
|
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway
Bortolotti D, Gentili V, Rizzo S, Rotola A, Rizzo R |
Cells | 2020 |
|
Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
Scribano ML |
Digestive Diseases and Sciences | 2020 |
|
Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment
Alothaid H, Aldughaim MS, El Bakkouri K, AlMashhadi S, Al-Qahtani AA |
Channels | 2020 |
|
A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19
González-Rubio J, Navarro-López C, López-Nájera E, López-Nájera A, Jiménez-Díaz L, Navarro-López JD, Nájera A |
International journal of environmental research and public health | 2020 |
|
Computational Immune Proteomics Approach to Target COVID-19
Tilocca B, Britti D, Urbani A, Roncada P |
Journal of Proteome Research | 2020 |
|
Efficacy and safety of tocilizumab in COVID-19 patients
Zheng KL, Xu Y, Guo YF, Diao L, Kong XY, Wan XJ, Zhao F, Ning FZ, Wang LB, Qiao F, Zhao JM, Zhou JH, Zhong YQ, Wu SX, Chen Y, Jin G, Dong YC |
Aging | 2020 |
|
NFATc3 regulation of collagen V expression contributes to cellular immunity to collagen type V and hypoxic pulmonary hypertension
Sheak JR, Jones DT, Lantz BJ, Maston LD, Vigil D, Resta TC, Resta MM, Howard TA, Kanagy NL, Guo Y, Jankowska-Gan E, Sullivan JA, Braun RK, Burlingham WJ, Gonzalez Bosc LV |
AJP Lung Cellular and Molecular Physiology | 2020 |
|
Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?
Mostafa T |
Sexual Medicine Reviews | 2020 |
|
Asthma-associated risk for COVID-19 development
Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H |
Journal of Allergy and Clinical Immunology | 2020 |
|
COVID-19: better trustworthiness of clinical evidence through clinical trials and systematic reviews.
Atallah ÁN |
2020 | |
|
SARS-CoV-2: una nueva amenaza
López Rodríguez CA, Boigues Pons M, Quirant Sánchez B, Teniente Serra A, Climent Martí J, Martínez Cáceres EM |
2020 | |
|
SARS-CoV-2: a new threat
López Rodríguez CA, Pons MB, Sánchez BQ, Serra AT, Martí JC, Martínez Cáceres EM |
2020 | |
|
Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community.
Lee HK, Knabl L, Pipperger L, Volland A, Furth PA, Kang K, Smith HE, Knabl L Sr, Bellmann R, Bernhard C, Kaiser N, Gänzer H, Ströhle M, Walser A, von Laer D, Hennighausen L |
medRxiv : the preprint server for health sciences | 2020 |
|
Comparative ACE2 variation and primate COVID-19 risk
Melin AD, Janiak MC, Marrone F III, Arora PS, Higham JP |
2020 | |
|
Nrf2 Activator PB125® as a Potential Therapeutic Agent Against COVID-19
McCord JM, Hybertson BM, Cota-Gomez A, Gao B |
2020 | |
|
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium
Ravindra NG, Alfajaro MM, Gasque V, Habet V, Wei J, Filler RB, Huston NC, Wan H, Szigeti-Buck K, Wang B, Wang G, Montgomery RR, Eisenbarth SC, Williams A, Pyle AM, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, van Dijk D, Wilen CB |
2020 | |
|
Empowering Children Through School Re-Entry Activities After the COVID-19 Pandemic
Capurso M, Dennis JL, Salmi LP, Parrino C, Mazzeschi C |
2020 | |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)